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IN T R O D U C T IO N
The Internet offers tremendous potential benefits to consumers in terms of 
increased convenience, choices and information. Yet, along with such benefits, comes 
new risks to consumers, including an increased risk from fraud, deception and 
misinformation (FDA and the Internet Conference, October, 1996).
New communication technology, such as the Internet, allow scholars to rethink 
definitions and categories. When the Internet is conceptualized as a mass medium, what 
becomes clear is that neither "mass" nor "medium" can be precisely defined for all 
situations, but instead must be continually rearticulated depending on the situation. The 
Internet is a multifaceted mass medium in that it contains many different configurations 
of communication. It does so by its very nature. The Internet plays with the source- 
message-receiver features of the traditional mass communication model, sometimes 
putting them into traditional patterns, sometimes putting them into an entirely new 
configuration. Internet communication takes many forms, from World Wide Web pages 
operated by major news organizations, to Usenet groups discussing folk music, to E-mail 
messages among colleagues and friends. The Internet’s communication forms can be 
understood as a continuum. Each point in the traditional model of the communication 
process can, in fact, vary from one to a few to many on the Internet (Morris & Ogan, 
1996).
Significant changes in traditional mass media have occurred. These changes are 
due to technological advances in the means of electronic distribution and handling of
information. The term most often used to describe the emerging social order is that of 
"information society." Briefly, "this refers to a form of society in which there is a high 
and increasing dependence o f individuals and institutions on information and 
communication in order to be able to function effectively in almost every sphere of 
activity" (McQuail, 1992, p. 1).
Researchers throughout the world have devoted much attention to the role of 
media in the field of health policy. Mass media have come to be recognized as a strong 
force in the field of preventive medicine. By focusing on health questions, media may
•*>
enable people to think about lifestyle issues, and perhaps, to change their behavior. 
Media-based advertising health campaigns can spread information and knowledge, and at 
best, offer deeper insight (Brannstrom & Lindblad, 1994).
Meaning is the core element of the advertising communication process. Among 
other reactions, audiences respond to advertising by relating advertisements to their 
backgrounds and experiences, distorting information, making attributions and both 
deriving meaning from and ascribing meaning to advertisements (Friedmann & Zimmer, 
1988).
Internet advertising is fundamentally different from traditional forms o f media 
advertising in the sense that consumers must seek out information. Currently, some 
marketers address this problem by integrating advertising with content; for example, 
using a game, a story or other incentives for the consumer visiting their site. In this 
environment, it may become harder to maintain the clear lines that exist between 
advertising and program content.
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Pharmaceutical advertising on the Internet is quickly becoming a topic of 
conversation for regulators. The U.S. Food and Drug Administration’s Department of 
Health and Human Services FDA and the Internet conference held in late October of 
1996 is indicative of the FDA viewing this as an issue that will continue to grow in 
importance and significance. More people will have access to the Internet, and health 
care debates will command greater public scrutiny with the constant changes in policies 
and procedures (M. Moncavage, interview, Feb. 12, 1997).
The FDA regulates prescription-drug advertising as it currently appears in 
various media. However, there is no set regulation for the Internet:
The Internet is an information source, a communication channel, a transaction 
vehicle, and a distribution tool. It is the phone, the newspaper, the TV, the 
shopping mall, the library, and the coffee shop. It is open 24 hours a day, 365 
days a year, available in every comer o f the world. It is making integrated 
marketing communications inevitable. It is an end-to-end process. (Gronstedt, 
1997, p. 9).
The purpose of this study is to examine the newest advertising tool, the Internet, 
and how pharmaceutical companies advertise their drugs in comparison to the more 
traditional print medium of magazines. Functional theory will be utilized as a framework 
for studying the Internet (Graber, 1997; Wright, 1976). The method of study will be a 
qualitative analysis of six selected pharmaceutical company Websites and magazine 
advertisements from three selected mainstream publications. The literature review 
illuminates the research that has been done on various methods of pharmaceutical 
advertising and promotion. The research also summarizes the limited research on the
Internet and how it has been used for advertising purposes. This study poses the 
following general research question: How are pharmaceuticals advertised on the new 
medium of the World Wide Web in comparison to another traditional medium such as 
print advertising in magazines?
Chapter 2 
LITERATURE REVIEW
Advertising is paid, non-personal communication through which an identified 
advertiser (e.g., a firm, a nonprofit organization, or an individual) sends a message to a 
target audience with the hope of informing, educating and persuading. Advertising, as 
part of an overall communication program, is a critical marketing and social process that 
offers significant value to advertisers, consumers and society (Aaker, Batra, & Meyers,
1992).
Advertising Regulation
The FDA may regulate only those prescription drug promotional activities that 
fall within the legal definitions of labeling or advertising. However, the agency has 
defined its authority in this area to cover virtually any material issued or sponsored by a 
drug manufacturer. The definitions of labeling and advertising taken together cover all 
information, disseminating activities by or on behalf of a prescription drug manufacturer. 
Labeling is defined as any written, printed or graphic matter upon or accompanying the 
drug. To be construed as labeling the material need not physically accompany the 
product, only "supplement or explain it" (Kessler & Pines, 1990).
Advertising is not specifically defined, but the FDA generally views anything, 
other than labeling, that promotes a drug product and that is sponsored by a 
manufacturer as advertising (Cohen, 1988). Once an activity falls within the definition of 
labeling or advertising, it must meet certain criteria. Labeling for both prescription and
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over-the- counter drugs must contain adequate directions for use. The requirements for 
prescription drug advertising differ from those that apply to labeling in one major 
respect: rather than carrying the full package insert, prescription drug advertising may 
contain a brief summary of it. False or misleading statements are prohibited. The 
agency’s regulations list 33 ways an advertisement may be false or misleading. Most 
commonly, advertisements are judged false or misleading if they selectively or 
inaccurately represent or report data, or make claims of superiority, based on less than 
adequate and well-controlled scientific studies (Cohen, 1988). Another FDA regulation 
is "fair balance" in advertising. In the fair balance test, the FDA views the advertisement 
in its entirety to determine whether it presents a balanced account of all clinically relevant 
information-risks and benefits (Kessler, 1990).
In recent years, the FDA has asserted its jurisdiction over an array of new 
promotional activities. In the FDA’s view, its mandate is to prevent physicians, other 
health professionals and consumers from being misled encompasses not only labeling any 
traditional advertising, but all promotional activities sponsored or financed by a drug 
company. The FDA’s Division of Drug Marketing, Advertising and Communications 
(DDMAC) is empowered to review all promotional materials, but has a small handicap: 
because of the First Amendment, it can require submission for review only after the 
company has begun to use the ads. This unregulated window of opportunity has 
produced a new opportunist, the rogue pharmo-capitalist. The new pharmo-capitalism is 
transforming the consumer, once known as the patient, into his own pharmacist (Critser, 
1996).
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The FDA’s position is that premature promotion may unfairly raise public and 
health professional expectations and also may lead people to believe that the product will 
be found safe and effective for a particular use for which there is no substantial evidence 
of safety and effectiveness. This conflict of vying for top-dog position can be seen in the 
immediate marketplace (Kessler & Pines, 1990). (see Appendix A).
The complexity of the market makes it difficult to trace any offenses in 
advertising pharmaceuticals. Control is not possible until the product has been placed 
into the market. The FDA must then identify the offense, or have to react to consumers’ 
complaints. Administrative agencies usually are created to deal with current crises or to 
redress serious social problems. Throughout the modem era of administrative 
regulation, which began approximately a century ago, the government’s response to a 
public demand for action has often been to establish a new agency, or to grant new 
powers to an existing bureaucracy. The development of new technologies often lead to 
creation of new government bureaus to promote and supervise these emerging 
industries:
The primary reason why administrative agencies have so frequently been called 
upon to deal with such diverse social problems is the great flexibility o f the 
regulatory process. An agency’s regulatory techniques and decision-making 
procedures can also be tailored to meet the problem at hand. They can influence 
conduct through a wide variety of informal methods (Gellhom & Levin, 1990,
p.2).
It is also not easy to formulate unequivocal criteria for the judgment o f medicinal 
claims. The powerful market forces now transforming the dynamics of therapeutic
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choice will humble medicine and the pharmaceutical industry (U.S. Food and Drug 
Administration, 1996).
Advertising Pharmaceuticals
The pharmaceutical industry is geared toward success that depends on creative 
advertising more than on innovative research. The information from drug companies is a 
powerful influence on prescribing, but the quality of the product information provided is 
considered by many to be substandard. It is often incomplete or misleading, and 
companies will emphasize the positive aspects of products, focusing on attributes that 
will give the agent a marketing edge, and not to provide all the objective data (including 
adverse effects and contradictions) required for comparative analysis (The Lancet,
1993).
A fundamental role of pharmaceutical advertising is to link effective therapy to 
individual patient needs. Pharmaceutical advertising transfers to physicians information 
on the actions and proper use o f medicines. Advertising is a crucial element of 
pharmaceutical innovation. Unless physicians are informed about the treatment 
opportunities offered by new medicines, there is effectively no innovation. Advertising 
provides physicians with an informed choice of carefully characterized agents, specific to 
the needs of individual patients (Levy, 1994).
Advertising helps in controlling the price of pharmaceuticals as companies 
compete for market share. Industry expenditures on advertising should be adequate to 
meet the objective of effectively linking therapies to individual patient needs. Strong 
links will mobilize the inherent potential of medicines to reduce the use of expensive
services, thereby reducing overall health care costs (Trends in Pharmacy, 1993). The 
fact is that the average expenditure per advertisement per medium has increased and that 
a relationship exists between the leading drugs advertised and the leading prescriptions 
filled, "implies that prescription drug advertising is o f financial benefit to pharmaceutical 
manufacturers" (Krupka& Vener, 1985, p. 193).
According to the FDA, the pharmaceutical industry spends more than $10 billion 
on promotion every year. By the late 1980!s, of nearly 16 million patients who visited 
doctors for depression, 70 percent ended up in drug therapy. Non-psychiatric physicians 
were brought into the prescribing fold (Critser, 1996).
Direct-to-consumer prescription advertising by pharmaceutical companies is 
expected to continue growing. From 1991 to 1992 pharmaceutical companies doubled 
their spending on direct-to-consumer advertising from $100 million to $200 million. The 
number o f pharmaceutical companies advertising directly to the consumer has increased 
from two in 1983 to about 15 in 1992. Although the majority of prescription drugs do 
not lend themselves to consumer advertising, drug companies are expected to expand 
their efforts (Winters, 1993).
Competitive Media Reporting data indicate that the pharmaceutical industry 
spent $1 billion on consumer ads for prescription drugs in the past five years. The 
amount more than doubled between 1993 and 1995 (Conlan, 1996). It is likely that in 
the absence of industry "promeducation" (educational presentations that are sponsored 
by particular pharmaceutical companies), alternative methods for the dissemination of 
information on important new drugs would be satisfactorily achieved via the rise of
10
publications similar to The M edical Letter and with online databases such as 
COLLEAGUE, DIALOG, and GRATEFUL MED. (Deader, 1994).
Pharmaceutical companies compete with one another for market share. Because 
the synthetic chemical commodities they produce are frequently similar 
pharmacologically and clinically, each company must differentiate its compound in some 
way from competing commodities. Corporate competition for market shares is therefore 
conducted around advertising and marketing strategies designed to set apart each 
compound (Goldman & Montagne, 1985).
However, the money devoted to promotion might be defined as wasteful in a 
traditional economic sense because the marginal promotional expenditure does not 
produce any increases in primary or selective demand. To remedy this situation, 
legislation could be considered for the purpose of stimulation decreases in the level of 
advertising expenditures while encouraging the industry to invest in additional basic 
science research (Mackowiak & Gagnon, 1985).
As pharmaceutical companies seek new ways to promote their products, there is 
concern about promotion to consumers through patient groups. Pharmaceutical 
companies defend this as promoting consumer choice, but by redefining illness and 
selling the disease, they create new markets (Consumer Reports, 1992, pg. 143).
The basic principles of a free enterprise system forcing fair prices through 
unrestrained competition are more applicable to the pharmaceutical industry now than 
ever before because of the advent o f managed care. Managed care is use of a planned 
and coordinated approach to providing health care with the goal of quality care at a
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lower cost. This type of provider usually emphasizes preventive care and often is 
associated with an HMO. Pharmaceutical advertising will remain a crucial element, with 
an increased emphasis on demonstrating improved outcomes for patients (Thompson,
1994).
Magazine Advertising
Advertising, regardless of medium, employs words, pictures, or some 
combination of words and pictures to communicate a specific message. Along the way, 
however, many things occur as receivers process the stimuli contained in the advertising. 
Research in the applied area of advertising effectiveness typically utilizes only 
recognition or recall measure as a dependant variable, while most research into the area 
of cognitive receiver response has centered only upon verbal processing. In fact, the 
general area of information processing, regardless of discipline, has relied heavily upon 
verbal information processing and has utilized recall measures as dependant criteria 
(Percy & Rossiter, 1982).
Studies by Mitchell and Olson (1981) and Wright (1979) have addressed the 
notion o f imagery in advertising communication, utilizing visual versus verbal stimulus 
elements, with beliefs, attitudes, and intentions as dependent variables. Significant 
relationships were found, suggesting a mediating role for visual imagery in increasing 
cognitive response to advertising. Both verbal and visual elements in advertising can 
stimulate imagery, and variations in words and pictures are known to have differentiating 
effects upon at least recall measures of communication (Percy & Rossiter, 1982).
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The way a message is conveyed (pictorially or verbally), whether the viewer is 
given some reference point for encoding the picture, and the type of claim made 
(objective, subjective, or characterization), have a significant effect on the processing of 
the information presented in the advertisements. These differences in processing are also 
shown to affect the viewer’s brand attitudes and purchase intentions (Edell & Staelin, 
1983).
Communication research interest in the elderly has focused on how they use the 
media and how the media portray them. The elderly, particularly women, appear to be 
under-represented in magazine advertisements in comparison to the general population. 
This pattern holds for many types of magazines. Because an advertisement is seeking to 
make a product attractive to its audience in order to encourage its purchase, it may be 
that advertising projects a less negative image of the elderly, in the case of magazines, 
than might have been expected from research on television dramatic programs. 
Nevertheless, the scarcity o f the elderly in magazine ads suggests that the elderly are not 
considered to play a major role in the consumer society (Gantz & Rainbow, 1980).
Notions about the information, persuasion and orientation of newspaper and 
magazine advertising have been tested. Product analysis suggests that the information or 
persuasion orientation of an advertisement is a consequence of the kind of product 
advertised: familiar products are more likely to be advertised with persuasion than less- 
familiar products, which require more technical information and are more likely to be 
advertised with an information orientation. The information or persuasion orientation of 
advertising is not a significant issue since product type appears to dictate the mode of
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advertising. Rather, the real issue is whether some products should, in any form, be 
advertised and this can only be resolved by those who pay for the advertising (Marquez, 
1977).
Some drug manufacturers were thought to have scaled back their advertising 
efforts under the Clinton administration. In 1993, President Clinton had a campaign 
plank of halting price gouging by drug companies. Magazine advertisement sales 
departments were at a loss as to how to generate revenue sources. However, most 
publishers and ad directors claimed that despite the likelihood of smaller ad flow as 
public pressure on drug campaigns mounted, drug manufacturers had realized that 
magazine advertising was far too valuable a medium from which to completely remove 
themselves. Even in the face of lower profits, pharmaceutical companies continued to 
tout the health value and scientific benefits of their products (Patz, 1993).
Pathways to Purchasing Drugs
Social scientists were first drawn to pharmaceuticals by critical studies of dubious 
practices by the pharmaceutical industry isuch as bribery, fraud in safety testing, dumping 
and misinformation (Braithwaite, 1984). The regulation of pharmaceutical promotion has 
created a level playing field. FDA regulations limit communication about a medicine. 
Advertising is what many people mean when they speak of promotion, although 
advertising is only a small part of promotion. Relatively little is spent on the high profile 
activities visible to the general public. For example, "less than 3 percent of Glaxo's 
promotional budget is spent on the types of activities that the public traditionally 
associates with promotion-advertising and promotional literature" (Levy, 1994, pg. 328.)
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An investigation by the Senate Special Committee on Aging found that much of
the money drug companies say they spend on research to develop new medicines actually
goes towards researching how to persuade doctors to prescribe their drugs. Drug
companies often give doctors free drug samples, prescription pads, free trips for doctors
and their spouses to attend company-sponsored seminars at posh resorts, "honoraria"
ranging up to $1,000 for being willing to attend, and cash rewards to doctors who write
a certain number of prescriptions (Gilbert, 1992).
In an era when patients have access to the Physician’s Desk Reference, when 
anyone can tune in to the Lifetime cable television channel, when almost every 
week, major scientific studies are reported on the evening news, and when the 
National Institutes of Health and the FDA themselves sometimes seek to 
publicize their own research findings, the regulatory line between scientific 
exchange and promotion is extremely fine (Edelson, 1980, p.34).
The producers of a piece of knowledge, in the form of scientific research, often 
seek to control or at least influence its dissemination, and there can be difficulties if they 
do not appreciate that the perspective of a journalist is not that of the producer but of the 
consumer (Wilkie, 1996).
Prescribing a medication is much more than meets the eye. Smith (1980), in a 
classic article, lists 27 "latent functions" of the prescription. A prescription has 
psychological effects, it is a means of communication, it shows power and facilitates 
social control, it produces income, and it has symbolic significance. Prescribing is a 
social act. It demonstrates the physician’s concern, and is an attempt by doctors to 
increase their good reputation (Kamat, 1995). Pharmaceuticals have a social life in that 
they follow a definitive process. First, they are prepared, usually in a technologically
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advanced setting, and marketed to wholesale suppliers such as ministries of health and 
private firms, as well as to retailers. Next, they are distributed to consumers by 
prescriptions or direct sale. The prescription is an intermediate phase. It provides the 
patient only with a piece of paper that eventually leads to purchase of the medicine.
After the pharmaceutical has come into the hands of a consumer, it will reach the final 
stage of its life, someone will use the medicine with the purpose of restoring, improving, 
or maintaining his or her health. The ways in which a medicine is taken constitute a 
crucial moment in its life. "Wrong use" may render its entire life meaningless. Finally, 
pharmaceuticals have a life after death. The fulfillment of their life purpose lies in their 
effect on the well being of the person who took them. The pharmaceutical company’s 
efficacy is its ultimate and decisive life stage (Van der Geest, 1996).
Traditionally a physician makes the purchase decision for the patient/consumer by 
providing him or her with a prescription. In the absence of a managed care mandate for 
generic or therapeutic substitution, the patient would then have the prescription filled by 
a retail pharmacist of his or her choice. During this process, the patient may receive 
information about the medications use, intended effects, and side effects from the 
physician during the office visit, from the pharmacist in the pharmacy, and/or from a 
leaflet included with the package of medication or provided by the physician or 
pharmacies (Van der Geest, 1996).
Because a consumer cannot purchase certain pharmaceuticals legally without a 
prescription, pharmaceutical firms who advertise directly to consumers are not looking 
for the immediate desired behavioral outcome: purchase. Rather, their objective is to
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encourage some other action on the part of the consumer that moves him or her close to
purchase, such as seeking additional information from a physician, pharmacist, or friend
(Williams & Hensel, 1995).
Waud (1992) indicates that advertising money from pharmaceutical companies
actually comes from the end-user. The money trail comes indirectly from patient's
insurance premiums or even more indirectly from insurance offered as a fringe benefit in
association with their jobs.
Let me point out that my quarrel is not with the drug companies altogether. It is 
more with their advertising end. Indeed, I can see no role whatsoever for drug 
advertising. I believe that practically all the problems associated with physicians’ 
interactions with the drug industry would vanish were advertising out of the 
picture (NEJM, 1992, p.353).
Pharmaceutical companies, as well as third-party providers of health care and 
their agents, are increasingly trying to cause patients to be switched from their originally 
prescribed medication to "me too" drugs marketed by the companies. These attempts 
are sometimes referred to as "switch campaigns." Pharmacists have been encouraged by 
pharmaceutical companies to identify patients taking a drug and urging patients to 
contact their physicians and ask to be switched. The pharmacists would receive a 
payment for each prescription thus switched f  Kessler, Rose, Temple, Schapiro, & 
Griffen, 1994).
Marketers realize that while purchase may be the desired behavior ultimately, 
intermediate behaviors may be prerequisites to purchase. Providing information rather 
than promotion is a valid and utilized motive for advertising and may be a necessary 
condition for most consumer purchases. Furthermore, firms such as pharmaceutical
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companies have multiple target markets, and several paths can lead to purchase (U.S.
Food and Drug Administration, 1996). Pharmaceutical manufacturers have increasingly
focused on the drug-buying public because they know that while the doctor writes the
prescription, the patient often guides the pen. Nearly one-third o f prescriptions for new
products is now written at the request of the patient, according to the trade magazine
Pharmaceutical Executive (Consumer Reports, 1992, pg. 142).
Because each prescription drug expenditure originates with the issuance of a
prescription, it is necessary to understand physician prescribing behavior and the factors
that affect it. It is estimated that two thirds of all patient visits result in the writing of a
prescription (Mackowiak & Gagnon, 1985).
There seems to be a generally held but naive view that advertisements are 
supposed to make you rush out and buy something. One demonstrates immunity 
to advertising simply by not making an immediate purchase. The absence of that 
knee-jerk response is supposed to prove immunity. This is a non sequitur. The 
sell is much subtler. All the advertiser may expect is that, other things being 
equal, if you subsequently have to make a decision it is more likely to be in the 
favor of the advertiser (Waud, 1992, p.352).
To disseminate drug information, there remains a middle person between 
physician and patient, applicable to most countries and respected by the public: the local 
pharmacist. The pharmacist rather than the doctor is often the person to whom patients 
direct questions about prescriptions and to whom they mention side effects. He or she is 
also well placed to spot inconsistent or dangerous prescribing, whether by doctor or by 
patient’s self-medication (The Lancet, 1996).
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The commodification of health and health care through the buying and selling of 
medicines has given rise to some lively debates in medical anthropology. The most 
prominent critic is Nichter (1989), who on the basis of research in South and Southeast 
Asia, remarked that there is a growing tendency to see health as something one can 
obtain through the consumption of pharmaceuticals. He calls this trend "defective 
modernization" and rejects it because it impoverishes the concept of health and gives a 
"false sense of health security,” (pg. 370).
Consumers often express a desire to learn about the qualities and potentials of 
pharmaceuticals. There is a lack of understanding of the differential distribution of 
knowledge among users and of the channels through which information flows in the 
popular sector (Nitcher, 1989).
In addition to this assessment of the lay population, research was done on the 
effects of promotion on pharmaceutical demand among professionals. Mackowiak and 
Gagnon (1985) found that in sales calls to physicians and medical journal advertising 
there was no correlation between changes in detailing or journal advertising expenditures 
and primaiy or selective demand. Moreover the results o f the study also indicated that 
(pharmaceutical) firms would be searching for media with larger primary and selective 
demand elasticity. Communication routes which show great potential for the future 
include direct to consumer advertising, physician cable TV, and on demand product 
information and advertising to physicians via a computer terminal in their office practice" 
(Mackowiak & Gagnon, 1985, p. 1195).
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Overview of the Internet
Created by the Defense Department in 1969 for fail-safe communications in the 
event of nuclear war, the Internet’s growth in the 1980's and 1990's was largely through 
ad hoc contributions by universities and through the private sectors marketing of 
personal computers. By the early 1970's, ARPANET (Advanced Research Projects 
Agency) was transmitting databases, software, hardware resources, storage space and 
computer power from computer to computer. This in turn, led to a separate military 
network (MILNET) for unclassified material. In the late 1970's, several universities 
began adding portions to the network, beginning with USENET (Users Network), and in 
the early 80's BITNET (for, Because it’s Time Network, a message retrieval service) and 
CSNET (Computer Science Network). The network called the Internet was not formed 
until 1983, when the Defense Communications Agency reorganized the Pentagons 
networks and began requiring certain protocols on all military networks. In April of 
1995, the National Science Foundation (NSF), which had become the closest thing to a 
federal authority over the Internet, formally turned over all responsibilities for running it 
to academia and private industry (CQ Researcher, 1995). As users of the Internet 
multiplied, the "domain" extenders required on the standard user’s address were 
designed to include ".mil" for military, ".edu" for academia, ".gov." for government, 
".com" for commercial and ".org" for organizations. In the following years, various 
universities would make contributions to the Net’s usability. The browser called Mosaic 
came from the National Center for Supercomputing Applications at the University of 
Minois-Urbana. The "gopher" searching tool came from the University of Minnesota.
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Most recently, the World Wide Web came from the European particle Physics 
Laboratory in Geneva, Switzerland (U.S. Food and Drug Administration, 1996).
Businesses have become more interested in the Internet since the arrival of the 
World Wide Web. It allows companies, organizations and individuals to create their 
own "home page," or Internet entry point. Individual home pages allow user interaction 
and instant connections to related home pages around the globe (National Science 
Foundation, 1994).
The World Wide Web is a widespread information service. It is all embracing in 
its capacity to interface to other information systems such a Gopher, WAIS, FTP, etc. 
The Web is based on a hypertext system. Hypertext is a system for linking documents to 
other related documents. Links are embedded within the text of a document in the form 
of highlighted words or images. Pointing and clicking with a computer mouse most 
commonly activates links. When the links are activated, the linked documents are 
instantly retrieved and displayed. The linked document itself can contain links to other 
documents, and the process can go on indefinitely. Gopher was the precursor to the 
Web; however, menu systems are less flexible than hypertext systems in that links can be 
set up from menus to information, but not within the information (Sanders, 1996).
The precise number o f Internet users is difficult to gauge. Before the recent 
estimate by the Internet Society, the best available estimate was one from late 1994 by 
Matrix information and Directory Services, available on-line. It counted 7.8 million 
users with computers that provided interactive services, 13.5 million users that could tap 
into computers that offered interactive services and a total of 27.5 million users with the
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capability of exchanging electronic mail. Observers warned however, that many of the 
accounts and computers counted in such surveys are seldom used (CQ Researcher,
1995).
Technology and the Internet
An important and expanding adjunct of the U.S. Food and Drug Administration’s 
regulatory function is the dissemination of information about drugs, medical devices and 
other regulated products to health professionals and consumer. An important new 
avenue of information distribution is the Internet, especially the World Wide Web. The 
Internet is enjoying unprecedented popularity in consumer and professional communities. 
For this reason, the FDA now provides a home page for those who want to learn more 
about the agency and the products it regulates. The FDA Internet home page 
(http://www.fda.gov) provides up-to-date, authoritative information on food, cosmetics, 
human and animal drugs biologic and medical devices. It includes easy to use full text 
searches and hot links to other FDA documents and to other government Internet sites, 
such as the Department of Health and Human Services site. In addition, users can 
download and print documents of interest to them. (Rheinstein & McGinnis, 1996).
Usage studies continue to reflect the growing popularity of the Internet, with 
17.7 million computer accounts reported last year, up from 10.3 million in 1995, 
according to Forrester Research (CQ Researcher, 1996). A total of 24.9 million 
computer accounts are expected to be added by the end of 1997. The Internet is a 
"potentially valuable tool" for the public but "carries risks as well as opportunities." A 
proposal for guidelines or policy on Internet prescription drug advertising is promised
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before the end of the year. The Federal Trade Commission (FTC) has jurisdiction over 
advertising and marketing. While the drug industry is eagerly awaiting the FDA’s 
proposal, "the basic approach is (already) there in the law" (OTC Business News, 1997, 
P- .18).
Advertising seeks to capture essential differences between competing products. 
(Levy, 1994). Yet, according to Forrester Research, by the year 2000 an estimated S6.6 
billion in retail revenues will be generated through the Internet. Furthermore, it can be 
assumed that the drug industry would not invest millions of dollars in these 
advertisements if their market research had indicated that the advertising campaigns were 
limited or of no influence. The avenues through which we receive our drug information 
are rapidly changing. Managed-care programs will be giving us more information and 
limiting our prescriptions in a variety of ways. Multimedia messages and computerized 
information will expand (Bowman, 1994).
Commercial applications of the Internet are still in their infancy, but in the early 
1990's pharmaceutical companies began using Internet Web sites to inform browsers 
about some of their products. In addition, most of those sites have hypertext link 
connections to other Web sites belonging to the same company, or to an unrelated entity, 
such as a voluntary health association or patient bulletin board. They, in turn, may have 
hyperlinks to other sites. The FDA is concerned about this and forbids drug companies 
from promoting off-label uses. The FDA is concerned about dangerous information 
from bulletin boards or elsewhere that might appear to be endorsed by a drug company 
because of a link (Conlan, 1996).
23
An increase in the use of the Internet to disseminate information about 
pharmaceuticals and medical devices has caused the FDA to evaluate how its policies 
concerning advertising and labeling should be applied to product information on the 
Internet and calls into question if additional regulations are needed because of the unique 
nature of the new medium (Snyder, 1996).
The major pharmaceutical companies believe that the Internet will be a key tool 
in their future communications mix. Many have plans to expand into other therapeutic 
areas, perhaps partnering with other companies. The results of their current efforts, 
guided by feedback from their customers, will impact future efforts as well as the 
evolution and creation of other companies' sites within the pharmaceutical industry. In 
developing a communications strategy utilizing the Internet, there is no wrong approach; 
there are no rules. Many companies are still struggling with how they define the 
Internet; some companies see it as an advertising vehicle, some as a communications 
tool, some as a combination of the two. Many manufacturers have used the Internet for 
product launches or to develop disease resource centers, while others focus on 
developing a database o f customers (Carlson, 1996).
Linking is an issue because the FDA does not like companies to use information 
that goes beyond official labeling. In the case of ethical drugs, the FDA has concerns 
about whether it is necessary to distinguish online between advertising and promotion to 
health care professionals or consumers, since both groups have access to the same 
Websites. Every drug company now has information on the Internet. Many sites include
(»
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corporate information directed at investors and the general public, such as quarterly 
financial reports (OTC Business News, 1997, p. 18).
The FDA does not have specific rules and regulations that apply to the Internet. 
Ms. Melissa Moncavage, Public Health Advisor for the Center for Drug Evaluation and 
Research indicated that the pharmaceutical companies advertising on the Internet are 
quite varied on their approaches/tactics. "There is no cohesive effort by the 
pharmaceutical industry from the DDMAC's point of view." If anything, Moncavage 
believes, "most pharmaceutical companies advertising on the Internet seem to be doing 
their own thing. There is variation in the approach. Some companies are targeting the 
consumer, others... doctors, and some are simply presenting general information" 
(Interview, February, 12, 1997).
The Internet holds a vast potential for health care marketing that is attracting 
increased participation by the pharmaceutical industry. The World Wide Web is the 
fastest growing media in history, with an estimated 35 million people who have access to 
the Internet. In 1994, Business Mailer Inc. reported that more than 120,000 physicians 
own computers with modems, and that the rate of growth is doubling annually (Liebman,
1995).
Results of a study of health care marketing executives on use and knowledge of 
the Internet showed that, o f the executives surveyed, only 16.5 percent were already 
using the Internet for marketing purposes. Of those already using the Internet, nearly 75 
percent were using the World Wide Web as a marketing tool. Some possible uses of the 
Internet for managed care companies, hospitals, or provider networks include: 1.
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maintaining up-to-the-minute provider networks accessed by subscribers, 2. Maintaining 
policy and procedure manuals for employees and providers, and 3. Offering providers 
access where only physicians can post questions or comments and see the responses of 
both company representatives and other physicians (Brakeman, 1996).
Six characteristics summarize what is new about this new medium. First is the 
great volume of information that is available. Second are the faster gathering, retrieving, 
and transmitting of information. Third is the greater control over the medium by 
consumers. Fourth is the greater ability of senders to target their messages to specific 
audiences. Fifth is the greater decentralization of the media. And sixth is the greater 
interactive capacity (Abramson, Arterton, & Orren, 1988). "The quest for information, 
especially among inquisitive, assertive, and aging baby boomers, alternately applauding 
and assailing ads virtually from birth, make continued growth with health topic 
advertising a natural fit with consumers and the Internet" (Conlan, 1996, p. 92).
Information retrieval and communication are two important aspects of the work 
of pharmacists and pharmaceutical scientists, and the Internet is an ideal medium by 
which these activities can be facilitated. The potential of the Internet is now being 
recognized, and in a year’s time, several pharmaceutical information resources have 
emerged on the World Wide Web (D'Emanuele, 1995).
Information that appears on a homepage may be different from what companies 
have traditionally used to promote their products through brochures, sales meeting, 
word-of-mouth or sales people going out. All of these things are available. It should be 
clear in terms of looking at a company’s homepage that it is coming from the company.
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It is impractical for FDA to force disclosure of a company name on every page or every 
screen in a company website, but it should be readily available (U.S. Food and Drug 
Administration, 1996).
The Internet makes the issue much more complex because everyone has access to 
it. It is impossible for one person, group, or company to control the Internet. The FDA 
may regulate what pharmaceutical companies, medical device companies and biologic 
companies put on the Internet, but cannot control what consumers or what medical 
researchers independently put on the Internet (U.S. Food and Drug Administration,
1996).
The issue comes to a head when a drug company or a device company is
distributing the information. Today if the drug company proactively sends out, for
example, scientific journal articles about unapproved uses of drugs, that would be a
violation that is treated as promotion. On the other hand, if a physician or a patient asks
for a copy of an article and they know what it is, the company is free to send it out. The
context is really determined by the receiver (U.S. Food and Drug Administration, 1996).
The FDA is concerned that keyword-based advertising on the Internet’s
directories and search engines is unique and superior to advertising on other media. For
advertisers, it offers access to a highly targeted audience on a cost-per impression basis,
while for the search engine companies, it is an easy-to-sell service that commands a
substantial premium over general display ads and banners. (Ubois, 1996).
Product-specific advertising is advancing cautiously on the Internet, because the 
FDA has no specific regulations that apply to direct-to-consumer ads. Despite 
jazzy graphics and audio, most manufacturers are treating Internet ads for 
products much the same way they do print. The FDA is considering different
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requirements for different media, but no decisions have been made (Conlan,
1996, p. 92).
Media Content and Society
For marketers, in general, advertising products which cannot be purchased 
directly by consumers can be effective in encouraging members o f the target market to 
seek additional information about the products, which ultimately might result in 
purchase. Pharmaceutical marketers should coordinate marketing efforts directed at 
consumers and their potential information sources, particularly pharmacists and 
physicians. ceDTC advertising, being favored by those in poorer health may well 
communicate with the perfect target market of pharmaceutical companies: those in poor 
health." (Williams & Hensel, 1995, p. 40).
It is a fundamental error to assume that the Internet and the Web, in particular, is 
simply an extension of previous media. If the FDA deems that the Internet is just 
another form of promotion that can be easily regulated with existing rules, then that 
makes it easy for the government. If there are differences between the Internet and other 
forms of promotion that require special rules, then this becomes a challenge for the 
agency (U.S. Food and Drug Administration, 1996).
Yet, the Internet is subject to regulation as specific events have shown in the 
past. In 1996, Virgin Atlantic Airways agreed to pay a fine o f $14,000 to the US 
Department o f Transportation for putting out misleading advertising on the Internet. 
(Keenan, 1996).
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The Internet Advertising Bureau, a trade group representing sellers o f online 
advertising space, made its debut in June 1996. The IAB is choosing to narrowly define 
advertising along traditional lines, and this is, "not effective in approaching the medium 
that is based upon advancing technology, and increasing consumer access" (Advertising 
Age, 1996, p. 15).
In 1995, the National Advertising Division (NAD) of the Council o f the Better 
Business Bureau made its first cyberbust at the end of that year, citing a company for 
false advertising on the Internet. The ruling, against Infinity Distribution shows that the 
NAD's rules will be applied no matter what the medium (Lucas, 1996).
The American Association of Adverting Agencies has created two disclaimers for 
copyright and liability, in case someone takes information from your site and uses it out 
of context on another site. These disclaimers can be used on any website. There is a site 
that is for the health of the NET code o f conduct (www.hon/conduct.html). A non-profit 
group in Geneva, Switzerland promulgates it.
The complex forces shaping the pharmaceutical market in the past two years will 
continue to reshape it. The negative market forces include: the significant number of 
blockbuster drugs going off patent and the resulting generic and therapeutic substitution, 
the lack of major new products replacing off-patent drugs, increasing price competition 
and the rising influence of managed care. Positive market forces include: improved R & 
D productivity, aggressive marketing to managed care groups, prescription-to- 
nonprescription switch groups, opportunities, and reduced operating expenses (Medical 
Advertising News, 1997, p.40).
29
Technology is perhaps the dividing line with physician’s views of pro or anti­
information dissemination among the lay population. Three elements must be taken into 
consideration: 1) What is the message itself? 2) Is it mainly promotional or education? 3) 
Who is the audience?
Petroshius and Titus (1995) found that physicians are favorably disposed to the 
advertising of pharmaceutical products both to consumers and other physicians, with 
differences emerging among physicians based on age, experience, practice setting, type 
and specialty.
Petroshius and Titus found older physicians view pharmaceutical advertising less 
favorably than younger physicians do. The researchers offered the explanation that older 
physicians were trained at a time when "advertising was sort of frowned upon by the 
medical community, and little, if  any, advertising was directed toward the consumer, "(p. 
47). In addition, "younger physicians are more likely to make an effort to keep abreast 
of new developments. They are also more responsive to patient inquiries and requests for 
prescription drugs"(p.49). The researchers conclude that this may be due to the 
evolution o f consumers becoming more informed about their medical options, when 
historically, the physician was viewed by the patient as "all-knowing."
While past research has found consumers to be favorably disposed to the 
advertising of pharmaceuticals (Alperstein & Peyrot, 1993), this is of little value to 
advertisers unless physicians respond favorably to patients' inquiries for advertised 
prescription drugs.
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Petroshius and Titus found that the physicians in their study reported a high 
degree of responsiveness to patient requests for prescription drugs, suggesting 
consumer-directed advertising to be an effective promotional tool, especially in light of 
Alperstein and Peyrot's findings that consumers are generally in favor of consumer- 
directed advertising of pharmaceuticals.
Reflecting the fact that pharmacy benefit managers, managed care groups and 
consumers now decide what pharmaceuticals are prescribed, pharmaceutical firms are 
turning to advertising agencies for an integrated marketing strategy. Each target 
audience requires a specific message. An increasing number of drug companies are 
tracking the entire process of treating an illness, rather than developing medications and 
simply marketing the product on the basis of clinical research. Tracking sales calls can 
be an important source of database information, giving companies a way to track the 
effectiveness of their promotions (M edical Advertising News, 1997).
Starting consumers off on the "path to purchase" by encouraging them to seek 
more information is a major goal of direct-to-consumer advertising for prescription 
medication. The attitudes of older adults are especially significant for pharmaceutical 
marketers because these consumers are heavy users of the drugs being advertised 
(Williams, & Hensel, 1995).
Using current and new technology, pharmaceutical companies realize that the 
old and proven ways of doing business are no longer going to work. Reinventing 
pharmaceutical marketing, advertising and promotion by capitalizing on the opportunities 
offered by technology is a must (Wind, 1994).
31
The Internet lends itself to the theoretical construct o f the audience as market 
(McQuail, 1987, p. 220). This theory identifies certain characteristics, namely: 
it specifies the link between media and their audiences as a consumer-product 
relationship, hence "calculative" from the point of view of the consumer and 
manipulative from the point of view of the consumer, and manipulative from the point of 
view of the sender. It gives little emphasis to the internal social relationships of the 
audience. The audience characteristics most relevant to this way of thinking are social- 
economic.
Wright (1976) suggests certain levels of functional analysis for communication 
activites.
The fourth level of functional analysis is rather abstract but crucial for the 
development of a functional theory of mass commuication. Mass 
communication, as institutionalized in modem societies, constitutes a social 
phenomenon qualitatively and quantitatively different from personalized 
communication (Wright, 1976, p. 205).
Lasswell and Wright (1960, 1976) are among the many scholars who have 
considered the functions and role of the mass media in society. Surveillance, the first 
function, informs and provides news and information. This includes the information 
that is essential to the economy, the public, and society. In performing this function the 
media often warn the public o f expected dangers. Graber (1997) suggests that the 
surveillance function involve two major tasks. For the political community at large, 
public surveillance focuses by publicity on selected people, organizations, and events. 
Private surveillance informs individual citizens in their private capacities about current 
events.
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Correlation is the second function, and this is the selection and interpretation of 
Information about the environment. Correlation is the editorial and propaganda content 
of mass media. The correlative function also serves to enforce social norms and 
maintain consensus. Through the correlation function the media can often impede 
threats to social stability and may often monitor or manage public opinion. Graber 
(1997) believes that by suggesting the causes and relationships of various events, the 
media may shape opinions even without telling their audiences what to believe or think.
As socialization, media function to communicate information, values, and norms 
from one generation to another or from the members of a society to newcomers. This is 
done in a way to increase social cohesion by widening the base of common experience. 
Graber (1997) indicates that most of the new orientations and opinions that adults 
acquire during their lifetime also are based on information supplied by the mass media. 
Mass media information provides the ingredients that the public uses to adjust existing 
attitudes and opinions to keep up with the changing world.
Lastly, most media content is intended as entertainment. Mass media expose 
millions to popular culture, music, movies, and television. Two arguments develop for 
the entertainment function of media (Wright 1976). One argument is that media 
entertainment serves to provide respite from everyday problems and fills leisure time. 
Others argue that the media encourage escapism, corrupt fine art, lower public taste, 
and prevent the growth of an appreciation for the arts.
Doris Graber (1997) added manipulation to these functions. Direct 
manipulation of the political process is widespread. "After decades of neutral reporting
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when most American journalists acted primarily as chroniclers of information provided 
by others, media now operate their own investigative units" (Graber, 1997, p. 12). The 
reason for the manipulation may be to expose misconduct and produce reforms. Or the 
reason may be to attract large media audiences and enhance profits.
Based on the review of literature on drug company advertising efforts and the 
Internet, the following specific questions were used to guide the investigation:
RQ 1. What type of information is presented? Does it inform the viewer?
RQ 2. What is the correlative nature of the information? What is the editorial content?
Is it educational, promotional, or otherwise?
RQ 3. Does the information provided act as socialization? Does it communicate values 
and norms?
RQ 4. Does the information have an entertainment value?
RQ 5. Is the information used for manipulation?
A qualitative analysis was chosen in order to address these questions. Qualitative 
research involves the careful, detailed description of that which is under study (Babbie, 
1995). Fundamentally, the goal of qualitative research is to preserve the form and 
content of that which is under study and to analyze its qualities, rather than subject it to 
mathematical or other formal codification (Lindlof, 1995).
Chapter 3 
METHODOLOGY
The goal of this study was to systematically describe the content of six 
pharmaceutical companies' Web sites for four sample Saturdays over a one month period 
in 1997. In addition, three mainstream magazines were examined during the same 
month. Advertising for the two different mediums were compared to each other. This 
was a descriptive study as well as being exploratory. There exists little research on the 
content of the World Wide Web; thus an initial exploratory study was needed to help 
explain this phenomena.
Sample
Based on the researchers judgment and the nature of the study, a purposive 
sampling scheme was seen as the best approach (Babbie, 1995). The six pharmaceutical 
company web sites which were chosen for study were Merck and Company INC., 
Bristol-Myers Squibb Co. INC., Pfizer INC., Eli Lilly Co., Schering-Plough Corp., and 
Ciba-Geigy Corp (see appendix B). The criteria in selecting these six companies were 
sales volume and that the company had a web site. Relying upon Dun’s Top 50 Business 
Rankings (1996) per SIC ranking by sales volume, all six fit the criteria of generated 
annual revenue and possessing a company web site.
The Standard Industrial Classification (SIC) is the statistical classification 
standard underlying all establishment-based Federal economic statistics classified by 
industry. The SIC is used to promote the comparability o f establishment data describing 
various facets of the U.S. economy. The classification covers the entire field of
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economic activities and defines industries in accordance with the composition and 
structure of the economy.
Companies were selected by having a website and their main business being 
pharmaceuticals. Of the six selections, Merck (4) represents the top-grossing company 
with $14,969,800,000 in sales and has a web site (http://www.merck.com/). Bristol- 
Meyers Squibb (5) has $11, 984,000,000 in sales and has a web site 
(http://www.BMS.com). Pfizer (9) has $8,281,300,000 in sales and has a web site 
(http://fdncenter.org/pfizer). Eli Lilly (20) has $5,711,600,000 and has a web site 
(http://www.lilly.com). Ciba-Geigy (25) has $4,806,640,000 and has a web site 
(http://www.ciba.com). Schering-Plough (27) has $4,657,100,000 and has a web site 
(http://www.myhealth.com).
Although the SIC rankings differ from the rankings used in this study (SIC 
ranking shown parenthetically), these companies were selected for having prescription 
pharmaceuticals as their flagship business rather than the other companies, which have 
other business entities under the same respective company name. The SIC 28 
classification is for chemicals and allied products which includes industrial inorganic and 
organic chemicals, plastics materials and synthetic resins, synthetic rubber, cellulosic and 
other manmade fibers; drugs; soaps, detergents, and cleaning preparations; perfumes, 
cosmetics, and other toilet preparations; paints, varnishes, lacquers, enamels, and allied 
products; agricultural chemicals; and miscellaneous chemical products.
As an example, Proctor and Gamble is ranked first on the SIC list, but their other 
product lines are vast, and prescription pharmaceuticals are not their core business as it
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is with, say, Merck which is ranked 4th in the SIC listing, but first for these particular 
research purposes as having pharmaceuticals as its core business. Each company from 
the SIC list was examined to see if it had a web site based upon the network listing 
Netscape for businesses, primarily using the search engine YAHOO! to find the sites. 
(http://www.yahoo.com/pharmaceuticals.)
In the same manner, the three mainstream magazines were examined for drug 
advertisements that appeared during the month of May. The three magazines were Time, 
Newsweek, and Modern Maturity. The magazines were selected on the basis of their 
audience reach as well as their readership. Specific content analysis studies confirm the 
status of Time and Newsweek as being typical of mainstream newsmagazines.
Smith(1990) and Moriarty and Popovich (1991) chose both Newsweek and Time because 
“of their national prominence, large circulation, and blend of news and feature subject 
stories” (Smith, 1990, p. 129).
Taken from the 1995 Audit Bureau of Circulation, the above mentioned 
magazines were selected for their ranking by total average paid circulation and the 
factors of recall and market niche. Of the 100 best-selling U.S. magazines, Modern 
Maturity is ranked second, Time is ranked 13th, and Newsweek, is ranked 19th. Factors 
that come into play for the selection of these publications are similar to the SIC ranking 
of pharmaceutical companies. For example, Playboy was 15th on the list as was Ladies' 
Home Journal with a ranking of 8th place. Although these magazines do rank higher 
than both Time and Newsweek, they are obviously targeted for a very core audience.
Time and Newsweek have a broader readership as national newsmagazines. Modern
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M aturity was selected because of its rank, and for the fact that it appeals to a specific 
age group that is more prone to be concerned with health care issues than other age 
populations.
Method of Analysis
The sites were selected because they meet the criteria of being listed in Dun’s 
SIC listing, and they each have their own website address. Babbie says that in a 
purposive sample, the researcher "selects a sample of observations which (one) believes 
will yield the most comprehensive understanding of (one's) subject o f study, based on the 
intuitive feel for the subject that comes from extended observation and reflection" 
(Babbie, 1995, p. 269).
Study of the websites occurred every Saturday for four-weeks, at 12:00 PM 
CST. Measurements and recordings were taken of each homepage and its links. A copy 
was made of each company’s homepage. The first Saturday was the benchmark for the 
study, and any differences observed to have occurred were noted. The study went two 
links (where allowed) deep into each menu item given on the homepage. The study was 
conducted at this specific time, because of time restrictions and computer accessibility of 
the researcher. The first step was to assess the homepage. Every Saturday the home 
page was printed and described by reporting what appeared on the page, and what links 
were available and where they lead. In preliminary research for this project, it was noted 
that the homepages have been witnessed to change in all manners, from layout, to 
graphics, as well as text and links.
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General categories were company history, drug information, investor relations, 
research and development, other.
After the description of the homepage and an itemization of the links, the menu 
items were clicked on in order (top to bottom, and/or left to right). A full description 
was given of what the link showed, and the critical probes were used to assess what type 
of information was presented.
A classification and description was given of the information presented on the 
linked page with its category heading, (e.g. patient narratives under the home page 
category of research and development).
For the homepages, certain clusters were established: company history, drug 
information, investor relations, research and development, other. ’’Clustering" is a 
general name given to the process of using and/or forming categories, and the iterative 
sorting of things-events, actors, processes, setting, sites-into those categories (Miles & 
Huberman, 1984).
The company sites and their presented information were clustered in a way that 
addressed the functional research questions: surveillance, correlation, socialization, 
entertainment, and manipulation.
Gathering information for the magazines was done for each issue for the 
month of May and was collected from the selected magazines at the end of the 
month. Each issue of each publication was searched by hand to find drug 
advertisements. Of any ads found, they were labeled by date, product name,
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company name, publication title, and if a website address was given. A photocopy 
was made of each ad.
A key element was whether or not the magazine ads had a website address. If  a 
website address was given, the researcher went to that specific website and recorded any 
of the differences and similarities between the magazine ad and the website information.
This information was compared to the information that has been presented on the 
selected pharmaceutical company Webster. Any differences or similarities were 
recorded.
Coding
Copies were made of the relevant material. All printed material was kept in a 
notebook. Once all the material was collected, a detailed description of the magazine 
ads and six Web sites was written. The content was organized into categories based on 
the research questions. Illustrative examples were presented to explain the items from 
each category, and tables were utilized to present the information in an organized, 
summary manner.
Interpretations
Inductive reasoning is the logical model in which general principles are 
developed from specific observations (Babbie, 1995). Qualitative interpretations 
result from the intensive analysis of a single case, or a few cases. The intimate 
knowledge gained of subcultures and organizations is written up in a way that 
discloses the author's insight. For interpretative science, meanings arise out of 
the intentions, practical purposes, and the reciprocal perspectives. This scope of
analysis is called ideographic. One does generalize in qualitative research, but 
not in a way that tries to obtain the scope of a universal law. Instead, the 
richness of the particular elements that are documented and the patterns or 
themes they exhibit allow the researcher to generalize to other cases of the same 
problem in the larger culture. It is not intended to explain a universal, ahistorical 
mechanism for behavior (Lindlof, 1995).
After this part of the study was completed, the interpretative method of subsuming 
particulars into the general was done. Subsuming particulars into more general classes is a 
conceptual and theoretical activity in which the analyst shuttles back and forth between first- 
level data and more general categories (i.e. information on the websites and the broader cluster) 
which evolve and develop through successive iterations until the category is "saturated" (new 
data do not add to the meaning of the general category) (Miles & Huberman, 1984).
Chapter 4 
RESULTS
Due to the large amount of information gathered from the six Web sites, the 
results were broken down into several categories based on the framework of the research 
questions. The first section describes the homepages of the Web sites. These pages 
alone deserve specific attention because they are the first pages users are exposed to 
when accessing the sites. The homepages all contained the same categories for linking 
options but under different names. The categories are as follows: company history, drug 
information, investor relations, research and development, other. After the findings of 
the categories have been reported, the type of information that is presented will be 
assessed. This information will be associated within the following functional categories: 
surveillance, correlation, and socialization and entertainment.
Home Pages: An Overview of Links
Merck (fig. 1) had its menu options on every linked page as it is presented on its home 
page. The menu items are: Site Map,News Products, Publications, Research, About Us, 
Topics fo r Health Care Pros and In Your Country.
Lilly (fig. 2) had menu options of: Who We Are, Targeted Disease Categories,Message 
from the Chairman, Strategic Focus, Financial Information, Press Releases, Corporate 
Citizenship, Speeches, Career Opportunities and Contact Information.
Pfizer (fig. 3) had a case scenario page that is presented before the actual home page is 
presented. The menu items are: Keeping People Well, Keeping Animals Well, Research 
and Development, About Pfizer, Investing in Pfizer and Career Opportunities.
BMS (fig. 4) had the menu options of: Latest News, Core Businesses, For Our 
Customers, For Our Investors, Media Connection, Message From the Chairman, A 
Look at BMS and Employment Opportunities.
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Schering Plough’s (fig 5) menu options were: Allergy Zone, Skin Cancer Zone, 
Hepatitis Zone, ToughActin’ Tinactin, Research Zone, Schering Plough Zone, Animal 
Health Zone, Cold Sore Zone and Prostate Cancer Zone.
Ciba, now Novartis, (fig. 6) (See Appendix B for further explanation). Who We Are, 
Health Care, Agribusiness, Nutrition, Investors, Media, Contact Us.
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Get lost? Not with the 
new space-age Merck 
site map!
The M erck Manual is the most widely used medical text in the world.
Welcome to our award-winning web 
site!
We are a worldwide research-intensive health products company.
This web site is provided as an educational and informational resource for Internet 
users around the world.
W e are...
□ Human Health Division 
3 Managed Pharmaceutical Care 
-  Manufacturing Division 
= Research Division 
= Vaccine Division
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Knowledge ls Powerful Medicine !
Welcome to Eli Lilly and Company
What we do at Lilly
Eli Lilly and Company is a global research-based pharmaceutical corporation headquartered in 
Indianapolis, Indiana, that is dedicated to creating and delivering pharmaceutical-based health care 
solutions which enable people to live longer, healthier and more active lives.
You are invited to learn more about our company through these pages:
□ who we are
□ targeted disease categories
□ message from our chairman
□ strategic focus
□ financial information
□ press releases
□ corporate citizenship 
-  speeches
□ contact° form ation
□ search this Web site
Your comments are important to us. Please give us your feedback.
Here is some information about our Web server.
[ Search I Feedback ]
Copyright <Q 1994.1997 Eli r.illv and Company. Lilly Corporate Center, Indianapolis, Indiana 462*5 USA. All rights reserved.
Figure #2
W e 're  p a r t  o f  t h e  c u re .
# P««p-
o kMptefanimate
fvtcflfch 4m4
« k n t
p f liw
InyM ttaf in 
pfixa*
tppntwMti
* New on the site
*  You're As Young As You Feel - 
Allowing people to mature with 
greater vitality and fewer medical costs 
is more important than ever.
*  1997 Pfizer Annual Shareholders' 
Meeting Report
<• Pediatrics & HIV: New Link - Pfizer 
is co-sponsoring this edition o f "The 
Cutting Edge Medical Report", 
premiering July 17 on the Discovery 
Channel.
<• American Medical Systems - a world 
leader in implantable medical devices 
to treat impotence, incontinence, 
urethral strictures and BPH.
*  Get In Step With Howmedica - Tour 
the innovative products and programs 
from a global leader in orthopaedic 
implant technology
hie products discussed herein may have different 
product labeling in different countries. The product 
information provided in this site is intended only for 
residents o f the United States.
keeping people well j keeping animals well | research and development | about
pfizer
investing in pfizer | career opportunities | search | site map 
C opyright €> 1996. 1997 Pfizer Inc. All rights reserved.
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MESSAGE FROM THE CHAIRMAN EMPLOYMENT OPPORTUNITIESQSSDDEfiEI
The mission of Bristol-Myers 
Squibb is: To extend and enhance 
human life K  by providing the 
highest-quamy health and personal 
care products. Our aim is to be the 
preeminent global @  diversified 
health and personalcare company. 
We invite you to find out more 
about our goals B | and strategies 
to maintain a leadership position 
around the world.
Copyright. Bristol-Myers Squibb Company, 1996
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Welcome to the Health Care Homepage
New s - Last updated 4/3/97
-  Schering Plough Research division now on line!
□ Check out the Allergy Alert for vour area in the Claritin Zone
-  Check out the Cold Sore Zone for vour lip needs!
~ New Symposia Announcements in Hepatitis Zone 
■ Claritin is A Logical Alternative to Seldane
c  Professional Information section now open in the Claritin Allergy Relief Zone 
c  Visit The International Divisions of Schering Plough 
= Professional Information section now open in Skin Cancer Zone
Welcome to the Health Care Homepage, brought to you by Schering-Plough.
new  skills
in the science of
Current Topics Novartis Aktueil
(Engtati) I (Deutscti)
Bt-Mais
Who We Are : Healthcare : Agribusiness : Nutrition : Investors : Media : Contact Us
: Search
Disclaim er
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The three-week study revealed that the websites changed very little other than 
minor variations of highlights on certain company home pages. For example, the Merck 
site had changed only with highlights presented on its home page that simply was a 
rotation of already presented material. In another instance, the update for Schering- 
Plough’s home page was dated April 3, 1997 and was not updated again during the 
course of the study.
There is a vast quantity o f information presented by these companies that ranged 
from investor relations to personal testimonials. However, the majority of the 
information was PR-friendly text. Specific brands of pharmaceuticals were a rarity, and 
when they were presented, the information was limited by a physician DEA (this is a 
license the Drug Enforcement Agency approves for physicians to dispense medication) 
code block or there were simply no other links. Most company websites gave general 
information about certain diseases, symptoms to look for and other related material, but 
very few actually "advertised" their products. Product names were given, as an example, 
Lilly’s Humalog was presented on its “managing your diabetes” link, but there was no 
continuation of that specific product other than a small graphic with the product name. 
There was no link to more information about that product. Other links simply gave 
overviews of diabetes, and when there was a hypertext link option, it simply went back 
to the original link page with the small graphic and product name of Humalog.
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Another example o f this lack of true advertising was the presentation of a specific
product followed by technical jargon that one could argue to be for physicians or
pharmacists rather than a lay consumer. An example o f this would be with Merck’s
Comvax link which in a press release gave a date and product name without stating what
the function of the drug was other than, “Comvax, haemophilus b conjugate
meningococcal protein conjugate.”
Surveillance Function
The first research question asked: What type of information was presented? Did
it inform the viewer? Did it provide news? The very essence of the websites was
information based. All of them gave information about their company. However, the
vast majority of the websites did not give information on pharmaceuticals. Although all
o f the companies posted a plethora of information, very little had anything to do with
drugs. Brand names were prevalent in some of the sites, but more detailed information
for the products were not found. The information that was given ranged from stock
quotes to press releases. Ciba/Novartis’ had a press release from May 13th in regards to a
business acquisition.
Basel, 13, May 1997-Novartis announced today the acquisition of Merck & Co., 
Inc.’s (located in Whitehouse Station, New Jersey) Crop Protection business for 
a price of USD 910 million. The deal includes the worldwide right to Merck’s 
business, which had 1996 sales o f USD 200 million with strong position in the 
high-value acaricide/insecticide and post-harvest fungicide markets. Also 
included are approximately USD 21 million in product inventories. Novartis has 
entered into a long-term supply agreement but will not be acquiring any of 
Merck’s manufacturing plants.
Merck also had a menu option of news. This site contained similar items as the 
other websites and their press release material. Again, as with other aspects of the 
websites, the information given in these press releases dealt more with business ventures 
than with actual drug products. Lilly’s press releases link was categorized by month for 
this year. Link one was to April 21st and showed the first quarter sales growth. The 
second link was to a May 29th (fig. 7) press release that is fairly typical of the other 
website formats. The press release deals with funding and research incentives.
Outside news sources were evident in a few of the company sites. BMS had 
media connection with one link to press releases. This one link had many menu items 
and latest press release information (April 29th, 1997). Other linked items were to 
entirely different subject/topic areas such as. news, industry focus, on line magazines, 
etc. This was an outside service that posted BMS's information. This service was called 
PR NEWSWIRE, a separate entity.
All of the sites had business information. The information ranged from stock 
prices to annual reports. Figure 8 shows the BMS link that had up-to-the-minute stock 
information that was fairly typical o f the other websites. Merck was typical of the other 
websites as it had an annual report. This screen had a mission statement link, investor 
relations and financial news. Under investor relations and financial news there were four 
more menu options. These were: corporate information, stock price, FAQ’s and 
financial news. The stock price also was given. It had the current DJIA price with an 
economic graph. This section also asked for your win/loss record with Merck stock.
F ig u r e  # 7Press Release
Mav 29. 1997 
(317) 276-5795
Millennium BioTherapeutics and Lilly Enter Into a Collaboration 
To Develop and Commercialize Therapeutic Proteins
Millennium BioTherapeutics, a New Subsidiary o f Millennium Pharmaceuticals, Enters First Major 
Pharmaceutical Alliance
Eli Lilly and Company (NYSE: LLY) and Millennium BioTherapeutics, Inc. (MBIO), a newly fonned 
subsidiary of Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM), announced today that they have 
entered into a collaboration for the discovery and development of novel therapeutic proteins. The alliance 
with Lilly is the first with a major pharmaceutical company.
The agreement covers a three-year program with Lilly providing S8 to $10 million m research funding per 
year with a provision to extend up to an additional two years at the same level of funding. Additional 
licensing fees, clinical development milestones and royalties will be payable by Lilly in connection with 
specific therapeutic protein product candidates identified in the collaboration and licensed by Lilly- Lilly 
has also agreed to mwlre a $20 million equity investment in exchange for 18 percent of the issued and 
outstanding shares of MBIO.
"Millennium Pharmaceuticals formed Millennium BioTherapeutics as a subsidiary to establish a focused, 
ftnmpl«nmnt«fy effort capable of realizing for our shareholders the maximum value inherent in 
Millennium’s commercial opportunities in biotherapeutic products.” said Steven Holt/man, chief business 
officer of Millennium Pharmaceuticals. ’Launching Millennium BioTherapeutics via this uniquely 
structured alliance with Lilly, a co m p a n y  with whom Millennium currently enjoys two other 
collaborations, represents a major step toward realizing this goal.”
Under the terms of the agreement, MBIO and Lilly will equally fend the collaborative program to 
discover and define the therapeutic utility of candidate therapeutic proteins. The collaborative research 
will create a pool of potential protein drugs that have defined therapeutic utility in in vivo models. Each 
company will have equal rights to select candidate therapeutic proteins from the pool for its exclusive 
development and cnmmpTCialiVahno- Both companies will share the right to use discoveries mnWe in the 
collaboration for the purposes of developing small molecule drugs. Millennium BioTherapeutics retains 
the exclusive right to use discoveries made in the collaboration for all other purposes, including to develop 
antibody therapy, gene therapy and antisense products. MBIO has transferred small molecule drug and 
predictive medicine rights to Millennium Pharmaceuticals.
"Lilly I**3 significantly enhanced its therapeutic protein discovery efforts with this important collaboration 
that will focus on the identification and validation of novel proteins," August M  Watanabe, M D , 
executive vice president, science and technology for Lilly. "A genomics-based therapeutic protein 
discovery effort is a critical component of our commitment to maintaining our leadership position in 
therapeutic proteins."
We are delighted to have Lilly, a world leader in the development, mannfiw-tnring anH madr-ting 0f  
biotechnology products, as a therapeutic protein partner," noted John Maraganore, Ph n  vice president 
and general manager of Millennium BioTherapeutics. "We are confident that Lilly's extensive research
. ....................................................................................................................................................................
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Up-to-the-Minute 
Stock Information
Symbol Date Time
NYSE:BMY 6/24/97 16:30
Open High Low Last Change Volume
77.75000000 85.75000000 77.50000000 84.75000000 +8.37500000 6349800
Earnings P/E Ratio Dividend 52-wk High
t---------------------
j 52-wk Low
3.20 24 0.38 80.37 41.50
Ramingc data is computed by adding the four previous quarters to achieve a trailing annual 
earnings number. Company's quarterly earnings results are released approximately three 
weeks after each quarter ends.
P&E Ratio is computed by dividing the stock price by earnings.
It is then rounded off to the next point
D ata provided, by  Quote. Com . Palo A lto . CA
Figure #8
In addition to this, outside investor resources were also linked to the company sites.
Ciba had investors link, which gave a long list o f investor relations’ contacts and stock 
information. Link one was to Novaritus stock that in turn linked to an outside 
program/server and hit the stock list in the £CN” section for Novaritus. Link two was to 
key dates, and this gave dates of various meetings, however, there were no locations or 
contacts. There were no links from this site. Lilly’s site also had financial information 
that gave annual reports, stock prices, and quarterly earnings releases. The first link was 
stock price, and there was a disclaimer as the server exited the Lilly website and linked 
to the Quicken Financial site. The second link was to the (most current) 1995 Annual 
Report. This information was introduced with the scenario of a girl with a disease that 
had been helped by Lilly’s products
Business descriptions of the companies were given on many of the websites. 
BMS’ core businesses had the menu options of: consumer products, medical devices, 
nutritional, and pharmaceuticals. Link one was to consumer products which 
automatically went to another menu screen where EXCEDRIN and other OTC products 
were displayed. These items were not linked to other pages. Detailed information about 
the products themselves were not given other than graphic representation. Link two was 
pharmaceuticals. This site had two menu options: pharmaceutical research institute and 
therapeutic areas. No drugs were displayed on either site only BMS’ research facility 
and their established procedures.
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Correlation Function
The second research question asked: What was the correlative nature of the 
information? What was the editorial content? Was it educational, promotional, or 
otherwise? Most of the websites were a combination o f educational and promotional 
material. The information that was presented would most o f the time be designated in a 
educational/informational manner. Most o f the websites would go into detail about 
ailments for illnesses, while espousing their corporate commitment to medical excellence. 
Again, the majority of the websites did not have product specific promotions. Yet there 
were instances where the “educational” forums would be sponsored by a specific 
drug/product. An example of this would be Schering’s Allergy Zone that featured 
Claritin. The site gave information on allergies and symptoms of allergies, with a Claritin 
logo on each link.
Promotional efforts included Merck’s Mediquiz (fig. 9) which offered browsers a 
free T-shirt. Four categories were presented: your body, medical discoveries, what’s in a 
name, and featured topic. Under medical discoveries, five questions were given. They 
were multiple choice on various topics, (i.e. when was the first Cesarean section 
performed?). Merck also had the disease information park. This option gave the link 
choices of heart disease, preventable disease, HIV/AIDS, glaucoma, and osteoporosis. 
The first link explored was heart disease. This link gave various background information 
on the disease, (i.e. you can quit smoking) and other elements for disease prevention. 
Brand names of Merck’s pharmaceuticals were not mentioned however. The second link 
was surviving high cholesterol with a full motion video that could be ordered. (It is the
Independence Day (USA). Canada Day. President's Day 
(Botswana). Simon Bolivar Day (Ecuador and Venezuela). The 
Day of the Sea (Japan).
July is full of holidays all over the world. While a web site can't 
hope to match such ceremony and celebration, we mark the month 
with another round of Merck's popular trivia feature, MedlQuiz!
Don't be timid; you might know more than you think. Find out by 
taking our quiz, and you could win a T-shirt!
The multiple-choice quiz features five questions in each of four 
categories. Every month the first 10 winners who submit their 
contact information will be eligible to receive a 
[free T-shirt. Even if you don't win, you still come 
out ahead with a store of fascinating facts, terrific 
tidbits, and just plain useful information.
s h ir t ! Now grab your virtual lab coat and stethoscope, 
and click on one of the following four categories.
Good luck!
/U . h h !  n n  « j i W (  •: i __________ . ^ t h u - s  < t*.-W hat’s in
hones
±>nt
Z 'm  n a m e *•rlnuruum
: : : / f t :  } s-
MERCK HOME ■  TOP or PAGE*
Copyright © 1996-1997 Merck & Co.. Inc.. Whitehouse Station, NJ, USA. All rights reserved.
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same as the ad that may be seen on TV that shows white on black text for synonyms of 
heart disease, with the phrases of “artery goo,” “blood mud,” etc). Promotional material 
could be found with the research item which showed published scientific work, Merck 
scientists available for seminar presentations, Merck gene index, MRL (Merck Research 
Labs), and career opportunities. Link one had published science. This was filled with 
medical jargon. Link two had available speakers and gave names, summary of studies 
and addresses only. What was unclear was whether or not the speakers were available 
for hire.
Lilly also had correlative elements. Targeted disease categories had several link 
options with: CNS, endocrine, infectious, cancer, cardiovascular and diabetes. Diabetes 
was the only link option active (fig. 10). Link two was to the education center. This site 
had long menu items ranging from glossary, to caring for your feet all in regards to 
diabetes. All gave the option for medical questions to be written in and sent via e-mail.
Pfizer had keeping people well with various menu links: dealing with depression, 
and the allergy information center (which is divided by product information and 
educational sites). Link one was the allergy information center that had the menu items 
of information, games, pollen count, and a survey. “Zyrtec” (fig. 11) was the featured 
product that the site was built around. Link two had the survey with a disclaimer. The 
function of this option was typical of many of the websites in that they combined 
educational/informational material in the context of the company, (or in some instances) 
the product name.
Diabetes inform ation for health care professionals, patients, and
consum ers in the US only.
Figure #10
I to n ia to g  ■
insulin lispro injection (rDNA origin)
Diabetes N ew s and Events
Education Questions Medicai Diabetes Your
Center and Questions Games Comments
Answers
I  r
x\lUJ/y
^ W e lc o m e  to Manavine Your Diabetes! SM (AU format) 
rWAV format is also available)
Purpose of this Web She I Disclaimer I Trademarks
Home | Map o f  M YD [ Back ( Forward [ Search IComments
Crmvright O  1997 Eli Lilly and Company I Disclaimer I Tradem arks
Z y i r r s c
cttifuiat SH
P r n c n t e t  I o f  a
‘ Info Center
.Semes*=*«•
Pollen Count 
.Survey
K ick  t a  Horn*
topic
search
ser Survey
Fill out the information below and hit submit to 
see how you and other visitors to the Allergy-Info 
site are affected by your allergies. Please note 
that we are NOT collecting any personal data 
from this survey, and it is intended as a resource 
only. Thanks.
What region are you from?
(Our survey is limited to regions of the US)
Poftea C ount Information
1-M9-3-niL£S
To view poiita count information, click a region of the United States
Figure #11
How are your allergy symptoms today? 
severe 
bad
pretty bad
slight
none
During which season (or seasons) do your allergy
symptoms bother you?
spring
summer
fa ll
winter
What are you allergic to?
Grasses
Molds
Trees
As for promotional material, there was basically PR friendly text on company
history. Ciba had for example, a health care link virtually the same menu items as did the
homepage and the who we are link. Link one was to consumer health that was a
synopsis of PR information. BMS had similar information with message from the
chairman, which had no links and gave some PR friendly text about the company. Ciba
had promotional material that was on a company wide level. This sort of information
was typical of all of the companies involved in the study.
As one of the world’s leading life sciences companies, Novartis is dedicated to 
creating value for its customers in the areas of Healthcare, Agriculture and 
Nutrition. Our commitment to health, safety and the environment (HSE) is part 
of this dedication and is inseparable from our activities, our identity and our 
values. Excellence in health, safety and the environment is not at odds with, but 
is rather intimately connected to our goal of providing the world with innovative 
products.
BMS had the company profile site. This site gave varied information such as 
general statistics of the company, earnings, and the number of employees, etc. Lilly had 
message from the chairman which simply showed the picture of the CEO and presented 
some PR friendly text. Lilly also had corporate citizenship (fig. 12). This menu item had 
many link options with: community, global philanthropy, and environment. Link one 
was global philanthropy. This link presented text regarding a $66 million philanthropic 
PR piece that had a link to a financial information option. Link two was the financial 
information link. This had various menu items ranging from grant guidelines to 
employee directed giving. As was common with all of the websites, drug specific
T he belief that private enterprise has a special 
responsibility to contribute to the progress of 
society has been basic to the philosophy of Eli 
Lilly and Company throughout its history. This 
belief is a legacy of the Lilly family, who founded 
and led the company, and Lilly employees, who, 
for more than a century, have traditionally 
supported nonprofit organizations that help 
strengthen the fabric and enrich the quality of life 
of communities and nations. Through financial 
grants, the donations of products and equipment, 
and the volunteer time and expertise of its 
employees, Lilly offers assistance to organizations 
whose programs help meet the needs of people in 
the areas of health and human services, education, 
civic affairs, and culture. Its product donations 
provide ongoing support to the developing world. 
The company also contributes to disaster relief 
efforts. The commitment to good corporate 
citizenship reflects the fundamental concern of the 
company and its foundation for the well-being of 
people and the quality of life. It is a way to share 
Lilly's success, to invest in the future, and to give 
back to society. It is an integral part of the 
company's mission.
In 1996, Lilly contributed more than $66 million 
in cash and product valued at net-wholesale price 
to charitable organizations around the world and 
joined the circle of companies in America with the 
most generous records of giving.
F IN A N C IA L  IN F O R M A T IO N
t vsii n toD iscr
[ Corporate Citizenship Index ]
[ Home | Search | Feedback ]
C o pyrigh t©  1997 Eli Lilly and Company
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promotions were not prevalent. Promotional and educational material was on a macro­
level in that it dealt with the company or the industry as a whole.
Socialization Function
The third research question asked: Did the information provided act as 
socialization? Did it communicate values and norms? Granted, this is a bit more 
subjective in nature and does ask for some interpretation by the researcher, but there are 
instances of both cases. For example, Merck has in your country with links to different 
countries: Canada, Japan (fig. 13) and Italy. For example, the link to Canada, had 
English and French language options. Link two was the English option. This had 
additional menus with different options, quizzes, patent legislation, etc. Lilly was even 
more culture specific with who we are gave a company overview with linked options 
ranging from the history of the company to major facilities. The site showed the history 
of the company and general background with dates and locations. Other sites listed 
many countries. As Merck’s site had Japanese language, one of the company sites had 
Italy as an actual link and when explored further, the site was discovered to be in the 
Italian language. The transmission of the companies onto the worldwide stage was 
evident in much of the information given in the sites. Most o f these companies are global 
in their capacities. Almost all of the literature have each of the companies describing 
themselves as, “global research-based,” “world leader in life sciences,” or some other 
similar capacity.
Schering had two options that transmitted the norms of individuals wanting to fit 
in with society. Cold sore zone is a site that had brand names with graphics. “Viractin”
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brand name was the one link option. Link one was Viractin, and this link presented a
narrative of a self-conscious individual with a cold sore.
That person is staring at my lip...or at least it seems that way. When you have a 
cold sore, it feels like the whole world is looking at the throbbing blister on your 
mouth. It’s no wonder that cold sores seem to hurt your ego as much as your 
lips.
The Prostate cancer zone had the linking options: patient information directory, 
professional information (which is password protected), and Schering patient support 
programs. The Schering patient support group gave various scenarios and the browser 
could order certain videotaped programs. The website transmitted the value of 
community, in that prostate sufferers would know that there were other men like them, 
and Schering was concerned about their health. An example of this was the video, 
“Committed to Life” and this had a brand name link to “Eulexin” which went to 
prescribing information about this specific product that one would find in printed form 
when a prescription drug was prescribed. The researcher was unable to view the 
videotape at the time.
Another value that the websites transmitted was by playing upon the booming 
U.S. economy. The option/opportunity for working in the pharmaceutical industry was 
prevalent in almost all of the company website. Lilly had a summer intern program (fig. 
14). BMS had an employment opportunities site with many menu items that were for 
specific positions, (i.e. manager of strategic procurement management positions, etc.) 
Link one was to the manager of strategic procurement management position; this gave 
the details of the position and the requirements for consideration for the job. Link two
j MOMNESS HEALTH & FITN ESS {RESOURCE X PRESS
H I O m B N f S  L1N M
Figure #14
THE 
FITTING 
ROOM
The Fitting Room -- that little space of horrors 
where new life forms are discovered under 
unforgiving fluorescent lights. Don't despair. 
Help is on the way.
Dorothy. Women's Link fitting 
room attendant, will help you match 
your body type with the right 
clothing styles to bring out your 
true star material.
Y ou may already know what 
styles of clothing bring out your 
best features and hide your least 
favorite endowments. If you 
have a generous bustline, you 
know that a bumblebee t-shirt 
with horizontal stripes will 
make you look wider and 
shorter. And that black and dark 
colors make you look smaller or thinner and 
white and light colored clothing enlarges your 
overall look.
B ut there's much more to know!. As you 
navigate The Fitting Room with Dorothy, you'll 
learn how to best define your body type or types 
and how to choose clothing styles to help you 
look and feel your best. Plus Dorothy will fill 
you in on what styles to avoid and what to do 
about those " special features" you may want to 
downplay.
START BY SELECTING YOUR
BODY TYPE
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was in examining another of the positions. This was for associate counsel, and again, it 
listed similar things as the other positions offered. Schering also had similar options 
with its research zone. This had several menu options with R+D, career opportunities, 
news, about Schering Plough and e-mail. Link one was to career opportunities with the 
menu items of: current opportunities, rewards and recognitions, and benefits. Career 
opportunities ranged from guidelines for submitting your resume to benefits. 
Entertainment Function
The fourth research question asked: Did the information have an entertainment 
value? Most of the websites were straightforward in their presentations o f the 
information. Among all of the company websites there were no specifically designed 
entertainment items. Some sites had quizzes and games, other sites simply had fun 
theme graphics, like Merck's balloons. However, some of the websites (in the minority) 
did have some entertainment functions. For example, BMS had a site for the sole 
purpose of entertainment; Women’s Link, which is BMS’ Clairol Web site. This site had 
a mall display and had such options as FAQ’s and product information. Another feature 
that was connected to Women’s Link was the fitting room (fig. 15). This site gave 
recommendations for the most flattering way to dress.
Schering's the skin cancer zone had the links of: about skin cancer, about sun 
safety, and about treatment. Link one was to sun safety. This link gave menu items to 
other links, (i.e. UV index, important contacts). Link two was to important contacts. 
Address and number for the Center for Disease Control and the National Weather line 
were given.
The Lilly Summer Internship Program
At Eli Lilly and Company, we began our summer intern program more than 40 years ago and believe 
that we have one of the best in the country. Our internship selections for 1997 are complete, but we 
encourage you to visit our booth at campus job and recruitment fairs to explore the possibilities for a 
summer '98 internship.
We offer:
Challenging summer projects that provide opportunities to become actively involved in issues 
critical to our company. The projects are designed to utilize and develop the intem's talents and 
knowledge, as well as the leadership and communication skills essential to a successful career at 
Lilly. Students are exposed to all levels of management and usually present the results of their 
projects to top executives.
Interaction with other interns and many Lilly employees both on and off the job. For example, 
Lilly locates reasonably-priced, furnished housing so that all interns can get to know each other by 
living in the same area. Also, many social activities are planned throughout the summer to 
encourage informal interaction with other interns and Lilly employees.
Please see instructions on submitting vour resume.
See also information on internships in Elanco Animal Health.
Eli Lilly and Company is an equal opportunity employer.
T Indiana Employment Opportunities Index ]
T Home I Search I Feedback 1
Copyright O 1997 Eli Lilly and Company
Figure #15
ToughActin' Tinactin option is of course a brand name OTC product. This site had John 
Madden with Jocks in a work out room. One of the options from this site was for fun 
and games (fig. 16). This gave two trivia questions where the browser could guess and 
then send the answers via e-mail and if they got the answer right and were picked from a 
drawing, the participant could win $50. None of the other websites had any similar 
entertainment items. Some had quizzes, like Merck’s for its T-shirt, and others simply 
had short quizzes with basic medical questions:
Which is the longest nerve in the body?
a. optic nerve
b. sciatic nerve
c. spinal cord
Manipulation Function
The fifth research question: Was the information used for manipulation? As the 
literature review has shown, pharmaceutical companies have been under attack for 
disseminating false and misleading information. The information in the websites can not 
be held up to scrutiny at this time, yet the information that does appear on the websites is 
most favorable to the companies and their products.
The Schering Plough zone site may be considered the home page, but the 
corporate information listed “Myhealth” as the home page. In addition to a confusing 
web address, Schering had a manipulative angle in its presentation of the hepatitis zone 
(see figs. 17,18) this option gave various menu icon items that range from understanding 
your liver to upcoming symposia. This might have been misconstrued in determining
n r ,  y o u  t o u c h  i m o p o o  
5 C IT  TO IN I  B M M H i r
in  how
YOU FIRY 
TKEGAHE
TRAINING
U P S
WHAOOYA I SIGNING I RULE l^nprmiPn 
WIN! I UP I BOOK l XOfKOARD
HIM HONE
TURF
Ibugh Actin’ 
Tinactm
SciWfMiQ-Ptough 
For mare about vour health
 (C LI CK H U I ) _________
Figure #16
PROSTATE CAMGER 
ZQHE
COLD SORE 
ZQHE
AHIMAIHEAUH 
ZQHE
e a l th
AUERSY 
ZQHE
SXUfCAHCES 
ZQNE
HEPATITIS
ZQHE
TQUGR&GlHf
TIHAGUI
SCHEftlNG-PlOUGH
ZQNE
RESEARCH
ZQHE
Welcome to the Health Care Homepage!
N e w s  - Last updated 4/3/97
Schering Plough Research division now  on line! 
r  Check out the Allergy Alert for vour area in the Claritin Zone 
r  Check out the Cold Sore Zone for vour lip needs!
N ew  Sym posia A nnouncem ents in Hepatitis Zone 
Claritin is A Logical A lternative to Seldane
Professional Information section now open in the Claritin Allergy Relief Zone 
•" V isit The International Divisions o f  Schering Plough 
-  Professional Inform ation section now open in Skin_Cancer Zone
Welcome to the Health Care Homepage, brought to you by Schering-Plough.
Five Million Americans have Hepatitis. Do You?
F i v e  m i l l i o n  
A m e r i c a n s  h a v ew • v m
^  800-223-0179
The hepatitis B and C viruses are more common and can be more infectious than the 
AIDS virus. Yellowing of the skin or eyes can signal hepatitis B and C, although most 
people have no recognizable signs or symptoms. Untreated, hepatitis can lead to scarring 
of the liver or even liver cancer. You are at risk for hepatitis if you have been exposed to 
infected blood or body fluids through tattooing, body piercing or sharing razors or 
toothbrushes. Unprotected sex with many partners or experimentation with illicit 
intravenous drugs also puts you at high risk. Your doctor can do specific tests to 
diagnose hepatitis B and C. Get tested. In many cases, hepatitis can be treated.
GET TESTED
If you suspect you are at risk, see your doctor or call the AMERICAN LIVER FOUNDATION for
free information.
1-800-223-0179
GETTING HIP TO HEP 
WHAT EVERY HEPATITIS PATIENT NEEDS JOJOVOW 
UNDERSTANDING YOUR LIVER 
RED BLOODED BLUES 
PRESS RELEASES
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what company is responsible for the startling image of a child’s blue face and yellow eyes 
(the only two colors in the website). The magazine ad is the same as Schering’s web 
link. Yet the magazine ad is sponsored by the liver foundation (fig. 19). It was 
confusing in determining who was responsible for the ad. Pfizer had a few manipulative 
elements in its website as well. To begin with, when the hompage was initially 
connected, there is a brief teasing testimonial before the actual homepage is brought up. 
“I was 25 and could barely move. What kind of life was I going to have?” (fig. 20).
After this screen was flashed to the viewer for a moment, the homepage appears. Pfizer 
had a menu option of testimonials and this picture of this woman was among the options. 
What could be questioned is whether or not such testimonials are really true. It is not in 
the context o f this study to determine.
Pfizer constructed another manipulation of information. One option was for 
“The contribution of pharmaceutical companies: what’s at stake for America.” There are 
22 pages that follow this option which traces the history of the pharmaceutical industry 
and the political ramifications and conditions of operating under the regulation of the 
U.S. government.
Viewed from a long perspective, progress in health care has been one of the great 
successes of the twentieth century. This fact should be one of the premises of the 
current debate on health care reform. At this point it is not.. .there is no scientific 
way to place a dollar value on extending human life and improving its quality, or 
to measure what percentage of this extension is due to drugs. However, the 
value that each person would place on extending his or her own life expectancy 
from 54 to 75-21 years-is surely substantial.
B S W iiiw w
- c h r o n i c  hepatitis C  th is year alone, and  w ithin th e  nex t 10 to  .20 years tha t  numbe r  is 
expected to  triple. if you received blood befarelM O. either during a medical p r e c e d i n g ;  
as  a  medical treatm ent you are a t  risk for hepatitis C  Unprotected sex with nrany partnets;^>. 
o r the  use of illicit intravenous or intranasaldndjs can place youat greater rak for develop +*.-;■ 
ing hepatitis C  lndivtduals in occupations whereexpasure to  blood can occur^uch as h e a th  
care workers/emergency medical technicians an d  paramedics, may beath igherrisk  for: -
Figure #19
* If y o u rea trisk fo r h e p a titisC ^ ''mGrM JC* t l [ I f  you 'reatriskfor i " g e t te te d  In many cases; fiepatitis.C can be treated effec^ --- 
~  tivety. If y o u  iuspect you. are a t risk. see your doctor or call -:.-- ;. 
’ the AMERICAN LIVER FOUNDATION for free in fo rm a tio n .-^
1-888-4HEP-USA - -
www.Hverfoundation.orgt
Amertcon liver. 
Foundation
"I was 25 and could barely move. 
What kind of life was I going to 
have?"’
Melinda Sheppard 
Nantucket, Massachusetts
Today Melinda is avid about her aerobics. But eight 
years ago, she could hardly walk.
Pains that started in her left foot spread to her hips, 
wrists and ankles.
The problem was chronic inflammation of the joints.
Thanks to physical therapy and medicine developed 
by Pfizer research, Melinda’s active life returned.
And shortly thereafter, so did her smile.
We're part of the cure.
Copyright €> 1996. 1997 Pfizer Inc. AH rights reserved
Figure #20
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The manipulation of information also occurred when websites inquired about 
specific individual information. Schering’s allergy zone menu options had mailing list 
information. Link 2 was to the mailing list. This link mentioned the product name 
“Claritin” and gave a survey for demographic/mailing information for the browser to put 
into the given space. Another way in manipulating the information was through 
restricting access to certain information. Schering had a link to the health care 
professional. Password only or the DEA (Drug Enforcement Agency) number for 
physicians to access this link could only access this link.
Magazines
As for the magazine ads, similar themes emerged. M odem Maturity (fig. 21) is a 
bi-monthly publication. May/June was the issue used for the research. There were no 
pharmaceutical advertisements. However, there were a few of the same ads for the 
AARP pharmacy service. This evidently is a service provided by the Agency for the
Advancement of Retired People that does cost comparisons among drug manufacturers
;
for the least expensive drugs. Three brand names of presumably the same compound are 
compared on a chart: Lescol, Zocar, Pravachol. There is no further explanation as to the 
make-up or function of the drugs, so perhaps it is assumed that the target audience is 
familiar with the drugs. No website address was given.
The mainstream magazines have a different result than the highly targeted 
publication. Time and Newsweek both have prescription drug advertising in their issues 
for the month of May. For the month four issues were examined. The dates are the 
same for both publications: May 5th, 12th, 19th, and 26th. There were no pharmaceutical
in ow you can reel better 
even before you take 
your medicine.
Lescol Zocor Pravachol
20mg * 60 ccpiules 20mg * 60 tablets 20mg * 60 tablets
PharrridcyG<
AARP P tu m u cy  Service called one pharmacy from a major chain in each o f  the four cities m entioned above on 1/23/97 - 1/ 24/ 97. T he prices shown are actual prices 
on  d u r  dale. Prices m ay vary daily and from pharmacy to pharmacy. AARP Pharmacy Service's prices are valid nationally for the drugs shown until 7/31/ 97 .
As you can see from  the chart- 
above, one o f  the th ings we 
do at AARP Pharm acy Service 
is m ake sure you do n ’t have to 
pay m ore than you need to 
for the  m edications you need. 
W e carry  over 3 ,000  brand 
nam e and  generic prescrip­
tion drugs as well as a com ­
plete line o f  non-p rescrip tion  
health  p roducts that are all 
com petitively priced. We also 
have a 7-day-a-w eek phone 
service th a t ’s answ ered  by 
friendly  and  know ledgeable 
people. A staff o f  pharm acists
to fill your prescrip tions safe­
ly and answer your questions. 
Even fast and reliable delivery 
by mail that comes stra igh t to 
your door. For over 35 years, 
w e’ve helped m illions o f  
AARP mem bers feel better. 
W e’d like to help you too.
To get your free price quote, call 1-800-456-7821 . Ask for Department 112130
M o n d ay  - Saturday, 6am  to  10pm  &  S unday , 8am  to  i f  ig U f e  # 2  1
A4RP PHARMACY 
ZZ&ZZSERyiCE
from  RETIRED PERSONS SERVICES, Inc.
Reared Persons Services, Inc, which administers the AARP Pharmacy Service, is a separate ax-panag e n a ty  not owned or coocroUed by AARP
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ads in Newsweek’s May 12th edition. The breakdown of the data was by publication and 
date.
Surveillance Function
The first research question asked: what type of information was presented? Did
it inform the viewer? Did it provide news? Most of the magazine advertisements gave
information and informed the reader. All ads had the subsequent FDA label information.
All of the magazine ads presented vast amount of information ( fig. 22) as they are
required by law to do so. The information was the labeling risk information that the
ID A  requires. In this regard all of the ads provided information, even more so than the
websites. However, due to obvious space restrictions the websites gave a much more
vast array of information than the magazine ads.
Other types of information ranged from news to directions for use. Time’s May
19th issue had an ad for “Caveiject alprostadil for Impotence.” The ad was mostly text
with the headline, “Impotence. If your treatment hasn’t made the difference you
need...maybe you need a different treatment." The ad continued with the text:
When properly dosed, Caveiject produces an erection that lasts about one hour. 
So if your aren’t satisfied with your current impotence treatment, or if you 
though impotence couldn’t be treated at all, caveiject could be the answer. Many 
insurance plans, including Medicaid, will cover it.
In addition to this information, the ad gave safety information and quasi- 
directions for use. “It simply takes about 10 seconds to self-inject Caveiject into the side 
of the penis. This puts the medicine right where you need it. Once the ideal amount has 
been established, the erection usually lasts about one hour.” The company is Pharmacia
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& Upjohn, and their name was mentioned in the ad. No website address was given, 
however a 1-800 number was present for more information.
Correlation Function
The second research question asked: what was the correlative nature of the 
information? What was the editorial content? Was it educational, promotional, or 
otherwise? Most of the magazine ads were promotional in nature. Some could be 
considered educational simply by the specific information they gave. The magazine ads 
differed from the websites in that they specifically promoted a specific pharmaceutical 
product, whereas the websites tended not to. The May 26th edition of Newsweek had an 
ad that was for “Accolate zafirlukast.” The headline was "accolate twice a day helps me 
control my asthma." The ad had a picture of a young woman and her puppy. The 
company is Zeneca. The company name was not prominent. There was no website 
address. There were promotional and educational components of this ad which were 
typical of most o f the magazine ads. The promotional piece was with the selling point of 
the convenience of a tablet. “You know how frequently you have to use your rescue 
inhaler. By making Accolate part of your asthma treatment regimen, you may even 
reduce your reliance on your inhaler. With Accolate, you simply take one tablet in the 
morning, another in the evening.” The educational element was in the citation of medical 
studies. “Accolate has been shown to have a side-effect profile comparable to placebo 
(sugar pills). In fact, in over 4,000 people studied, Accolate was generally well 
tolerated.”
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Socialization Function
The third research question was: did the information provided act as a transmitter 
of culture? Did it communicate values and norms? The magazine ads were all in the 
English language, so there was no other foreign influences or options as there were in 
the websites. Therefore culture was not communicated. However, values and norms 
were communicated. Much like the Schering’ cold sore zone playing upon and 
individual’s vanity, there were a few magazines ads which did likewise. The May 19th 
edition of Newsweek had an ad for “metrogel/metrocream metronidazole topical,” with 
the headline, "Maybe its sunburn. Maybe it's skin irritation. Maybe it’s an allergy.
Maybe its acne. Maybe its Rosacea." In another ad there was a picture of a woman's 
face with discoloration (fig. 23). The product is from Galderma Labs. The company 
name was not prominent. No website address was given. Time's May 19th issue had an 
ad for “denavir penciclovir” for cold sores. The ad showed a self-conscious woman 
holding her lip with the headline, “new prescription Denavir blocks the virus in the cold 
sore, so it heals in 2-4 days.” The company is Merck. Their name was not in the ad. No 
website address was given.
Entertainment Function
The fourth research question asked: Did the information have an entertainment 
value? None of the magazine ads had sheer entertainment functions as did some of the 
websites. None of the magazine ads had quizzes, or games for the viewer to participate 
in. However, some o f the print ads could be considered “entertaining” as they were 
presented with a lighter flair and a more humorous angle. An example of this is the May
I V I H I  D C  1 1 3  3 i u n  i n ^ 'S 1 « * J W .
MAYBE IT’S AN ALU 
MAYBE IT’S ACNE.
ftrsistent redness or flushing in the middle areas of the 
face. Broken blood vessels. Acne-like bumps. These are 
all symptoms of rosacea—a skin condition that affects 
over 12 million Americans middle-aged and older.
Rosacea symptoms may come and go, but without treat­
ment, they may get worse over time. Over-the-counter 
medications may help temporanly, but to really get your 
rosacea under control, you need to see a doctor.
So don’t wait. Talk to a dermatologist today. And 
when you do, ask about MetroCream™ or MetroGel® 
the #1 doctor prescribed topical rosacea medication.
In clinical trials, patients expenenced the following individual 
side effects in order of frequency: skin discomfort (burning 
and stinging), redness, skin irritation, itching, or worsening of 
rosacea. The total incidence of side effects was approximately 10%.
MetroGel. I Metro Cream'
(metronidazole topical gel) / (metronidazole topical cream) 
Topical Bel, 0.75% I Topical Cream, 0.75%
R o sace a  th e ra p y  th a t  w o rk s .
FOR FREE INFORMATION 
ABOUT ROSACEA,
CALL 1-800-432-4909
C GaWBrma Lafcoraww, Inc 1996. Plec se» nan pag» tor moortam product rtmmaicn.
19th edition of Newsweek had an ad Atrovent ipratropium bromide with the headline, 
"break free from your runny nose" and a picture with a play on ball-and-chain with a box 
of tissues (fig. 24). The company is Upjohn. The name was not prominent. No website 
address was given. The Newsweek ’s May 5th edition was a cartoon ad for “prilosec 
omeprazole” (fig. 25). The ad showed a cartoon man holding his stomach. The headline 
is, "If your heartburn medicine works so well, why do your keep getting heartburn?"
The manufacturer is Astra Merck. The company name was not prominent. No website 
address was given.
Manipulation Function
The fifth research question asked: Was the information used for manipulation?
As with the websites and some of the examples of manipulation, the magazine ads could 
have had information that was not entirely accurate. Aside from this possibility is the 
fact that some of the ads did play upon or manipulate the emotions. Newsweek’'s May 5th 
issue had an ad for “rimadyl carprofen,” an animal product that was part of a four-page 
spread. The headline was "if arthritis pain took your dog out of the picture, where 
would you be, besides a little lost?" The picture depicted a family frolicking with the 
dog. The copy included:
You’ve always enjoyed those long walks with your best friend. Problem is, joint 
pain and inflammation can sometimes make it difficult for him to lead the way. 
That’s why it’s important to recognize the early signs. You’ll notice stiffness and 
difficulty rising, walking and climbing stairs. Your dog won’t act like himself. 
He’ll resist your touch, he’ll whimper and he’ll limp.
Ask your doctor about an exciting advancement for treating runny noses, 
ATROVENT® Nasal Spray. I not a steroid! It’s the first in a unique class of nasal sprays 
that actually stop runny noses where they start. Inot ananhhistwinei ATROVENT 
Nasal Spray’s special inhibitors provide effective relief without insomnia 
I wont keep you awakh [ or drowsiness. I^ qnt put you to ;leep~| And it can be safely used 
by children 12 years and older. ATROVENT Nasal Spray is available exclusively by 
prescription. Only your doctor knows if it’s right for treating your runny nose. Though 
most ATROVENT Nasal Spray users experience trouble-free relief, nasal dryness 
(approximately 1 in 20 patients) and mild nose bleeds (approximately 1 in 10 patients) are 
potential side effects* So ask your doctor about ATROVENT Nasal Spray, or call 
toll-free 1* 888* ATROVENT (287*6836) for a free brochure and money-saving coupon.
S T O P  IT F R O M  T HE  START.
See following page for additional 
important information.AN-6M7K
ATROVENT8 "
N A S A L  S P R A Y
(ipratropium bromide)
Figure #25
FREQUENT HEARTBURN SUFFERERS:
If your heartburn 
medicine works 
sowell, why do 
you keep 
gutting 
heartburn?
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This is a Pfizer product and the name was displayed prominently. The web site 
address is www.pfizer.com/ah. The May 26th issue of Newsweek had an ad for no specific 
product other than publication material for Alzheimer’s ( fig. 26). The headline was,
"he's working to help Alzheimer’s patients remember, and that's helping families hope." 
There was some testimonial material and snapshot pictures. No company or product 
name appeared. There was a website address http://www.phrma.org.
Time’s May 5th issue had no product name, and no company sponsor. Rather, it 
was much like the Alzheimer’s ad in that it was an awareness ad for Hepatitis. The 
headline was, "get hip get tested get treated." A website address was given with 
www.liverfoundation.org. This ad was similar to a pharmaceutical website. Time’s May 
26th editions had the hepatitis ad (fig. 19) which has been described before. This ad 
varied a bit in its layout, but the text and message was the same.
There were six website addresses from the magazine ads. Some were from 
specific pharmaceutical companies; some were general information and were unnamed. 
The sites are described and the research question most applicable to the particular 
website is discussed. It should be noted that many of these sites contain elements that 
are relevant to all of the research question areas. All of the sites contain information. 
Some of this information is promotional in nature, some of it is manipulative, and some 
of it transmits certain mores and norms.
The first website address that was explored was Flonase from Glaxo Wellcome 
www.flonase.com (fig. 27). The homepage for this particular product was not the 
homepage for Glaxo. Menu options for this page was understanding allergies, allergy
Z h  0  I m  0  r  S patients remember, 
and that’s ( ^ [ p ^ g  f a m j|je s  h o p e .
Are/ Unterbeck 
pharmaceutical company researcher
"When I was a young student, people used to think that memory
loss and dementia were a normal part of aging. Today we know
that in many cases, the real cause is Alzheimer’s disease. As a
pharmaceutical company researcher. I am committed
to  finding ways o f  treating this disease.”
"Currently, there are about 4 million people
in the United States with Alzheimer's disease.
Unfortunately, this number will dramatically increase
as our population ages. My company is searching
for treatments that might slow down, halt or maybe
even reverse the progression o fK 5 Figure #26
Brain celis from 
an Alzheimer's pooent.
“W e think A lzh eim er’s d isease  has 
Several different Causes.” says Axel Unterbeck. a 
pharmaceutical company researcher. "Some forms are 
genetic while others might involve additional factors. 
Because it affects memory and learning, it's one o f the 
most complex diseases w e know of." Unterbeck and his 
team of researchers are working on genes that are linked 
to  Alzheimer's disease. "Four genes have been identified so 
far," Unterbeck says. "These gene discoveries give us, for 
the first time, a realistic hope to find a cure."
Call 800-862-5110 for our free booklet on Alzheimer's 
or visit us on the internet a t http://www.phrma.org. Find 
out m ore by calling the Alzheimer's Disease Education 
and Referral Center a t 8 0 0 -4 3 8 -4 3 8 0 .
Nasal allergy sufferers:
Ask your doctor about9 piiKasoneproponaq
N*lltiU[ Ml
the allergy medicine 
that unstuffs 
your nose.
Click on nose aoove for audio
Click here to  receive your free allergy kit 
including a $5 savings certificate.
m
A bou t ridhase
Product
information
[ Understanding Allergies ] [ Allergy Library ] 
[ About Flonase ] [ More Cartoons ]
[ Product Info ] [ Free Allergy Kit ]
[ H o m e]
Intended fo r  U.S. consumers only.
C opyright G laxo W ellcome Inc. 1996  
A ll Rights R eservFigure #27
library, about flonase, more cartoons, product info, free allergy kit, and home. All links 
had expanded information about the product and all links link back to the homepage o f  
Glaxo. There w as also the additional item o f  a $5 savings certificate when the browser 
chooses a free allergy kit. This site provided the standard risk information that was seen 
in the magazine advertisement. There was a promotional aspect with this site as it gave 
the viewer an incentive to purchase the product with a discount feature. In this light it 
could be said that there is some manipulation in the site as there is the proverbial 
“dangling carrot” to purchase the product with a rebate incentive.
The next w ebsite address explored was from the Alzheimer’s advertisement 
www.phrma.org. (fig. 28 ).This address actually went to a site called phrma for America’s 
pharmaceutical companies. Menu items included: Phrma homepage, members, facts and 
figures, health guides, current news, industry issues, search, and new medicines in 
development. The site had a statement that Phrma membership, "represents 
approximately 100 U .S. companies that have a primary commitment to pharmaceutical 
research. These companies are discovering, developing and bringing to market 
medicines that improve our health and quality o f  life, etc." When explored a bit, the links 
did not go  to  other pharmaceutical company sites. Some recognizable companies were 
mentioned in the text, but there were no hyperlinks. It is unclear at the time o f  this 
research i f  Phrma is an umbrella name for specific companies, or is an entity unto itself. 
N o further data was given. Product information w as presented, only in name rather than 
affects and other relevant information. For this reason, this site was manipulative in its
* MEMBERSHIP 
Facts & Figures 
*  H e a l t h  G u id e s  
* D r u g s  In  
D e v e lo p m e n t
Cu r r e n t  n e w s  f
' STATE *
i n d u s t r y  I s s u e s  <? 
S e a r c h  m
G e n o m i c s :
A G|0bal Resource * • * # * * * «
**** Searching For Answers To Alzheimer's newi
PhRMA membership represents approximately 100 U.S. companies that have a primary 
commitment to pharmaceutical research. These companies are discovering, developing and 
bringing to market medicines that improve our health and quality of life~as well as reduce 
the overall cost of healthcare.
While visiting here, be sure to stop by our sections on Drugs in Development, industry Facts 
and Figures, and our consumer Health Guides series.
To find out more about issues concerning pharmaceuticals, look at Current News. This 
section will discuss the hot topics and state issues that we are currently following.
Our new Genomics section provides a dynamic and accessible information resource on 
emerging genomics-related issues for members of PhRMA and American Institute of 
Biological Sciences (AIBS).
Thanks for visiting. We will continue to update this web site to keep you abreast of new 
developments. If there is anything you would like to see here or have any comments please 
let us know.
Sincerely,
Figure #28
Sidney Taurel 
Chairman
Alan F. Holmer 
President
I PhRlMA Home Page I Members I Facts and Figures 1 Health Guides I 
| Current News ) Industry Issues | Search | New Medicines in Development |
Copyright © 1996 PhRMA. All rights reserved. 
Questions and Comments: Webmaster 
Or fo r  more information contact: 
Pharmaceutical Research and Manufacturers o f America 
1100 Fifteenth Street, NW  
Washington, DC 20005
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information as it was simply unclear what exactly product and company is featured. The 
lack o f  clarity enhanced the manipulative nature o f  this site.
The next website address explored was from the hepatitis ad. The homepage had 
the menu options of: information, ALF publications and videos, ALF services, activities, 
and groups please sign our guest book. What was o f  keen interest was that the ad that 
appeared in the magazine was the same ad by Schering-Plough in its hepatitis zone menu 
option. On this particular page, there w as a link to the American liver foundation, but 
there was no link from the American liver foundation to the Schering site. This site 
could be seen as being manipulative, as there was confusion about the website address 
given and the actual site. The “darkness” o f  the ad and the seemingly “other-worldly” 
layout o f  the ad also use scare tactics.
The next address examined was www.migrainehelp.com. This was for Imitrex 
(fig. 29). The site had hypertext link options o f  symptoms, treatment programs, detailed 
diagnostic screening, complimentary support materials, and free subscription to  
Headway. In addition there was a main menu options which linked back to the Glaxo 
W ellcome homepage and the option o f  sharing your thoughts and experiences, which 
was in survey format. Imitrex option simply provided more information about migraine 
headaches and little about the product other than lay perspectives and testimonials. This 
site provided news and information about the product. It could also be considered to be 
correlative as it has strong promotional emphasis on how the product aids the sufferer.
Zocor was the other prescription product from a pharmaceutical company 
magazine advertisement, www.zocor.com was the address (fig. 30).
Welcome to the
Migraine Resource Center
Glaxowelicome
Figure #29
Welcome to the Migraine Resource Center.
Those who suffer from migraine headaches know how painful, debilitating, and isolating 
they can be. The good news is now there is more information available about migraine than 
ever before, as well as promising treatment programs that may help you. If you think you 
may have migraines - or have been diagnosed by a physician as a migraine sufferer - you 
should see your doctor or allied health care professional to discuss possible treatment 
programs.
Here in the Glaxo Wellcome Migraine Resource Center you can leam about some of the 
triggers, symptoms, and treatment programs for migraine, take a free detailed diagnostic 
screening, receive complimentary support materials such as a free subscription to Headway, 
the migraine newsletter, and much more. Glaxo Wellcome Inc., a pharmaceutical research 
and development company and sponsor of this site, is dedicated to the better understanding 
and treatment of migraine.
As this site will be frequently updated, we urge you to visit us often - to get the latest news 
as well as to share vour thoughts and experiences. We want the Glaxo Wellcome Migraine 
Resource Center to be a place you turn to for the information and support you need to live 
better with migraine.
To get started, click on Main Menu.
Next Topic Previous Topic Home 1
IMITREX*
(sumatriptan s u c c in a te )
IMITREX Tablets
Important Intormabon
Literature 1
Please see important information for IMITREX® s^umatriptan succinate^  Tablets.
Intended for US residents only. 
©Copyright Glaxo Wellcome Inc. 1996 
All Rights Reserved 
Comments/Questions?: webmaster@migrainehelp.com
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welcome to
www. z o c o r . com*
brought to you by Merck & Co.. Inc.
(Merck is also known as MSD, Merck Sharp & Dohme and others outside o f  the USA.)
Merck & Co.. Inc.. is a worldwide health care company that is committed to developing and marketing 
innovative products that treat conditions which impact your quality of life.
The information found here will help you to become better informed and educated about heart disease, 
which could affect your health, lifestyle and future. We believe that the better informed you are, the 
more involved you can become in partnering with your doctor to improve your overall health. To assist 
us in providing you with the most appropriate information, please select one of the following:
z 1 am a resident of the United States of America. 
z I am a resident of another country.
Merck develops products and services for a wide variety o f conditions, including high cholesterol, high 
blood pressure, osteoporosis, enlarged prostate, glaucoma, and preventable diseases. Please visit our 
Disease Infopark for more information.
When you have finished visiting ZOCOR.COM , please use the buttons on the top of each page to 
navigate to sections o f the Merck site to view information about other medical conditions and products 
that Merck has developed.
Copyright © 1996 Merck & Co.. Inc.. Whitehouse Station. NJ, USA. All rights reserved
* ZOCOR® (simvastatin) is a trademark o f  Merck & Co.. Inc.. Whitehouse Station. NJ, USA, and 
registered in the United States Patent and Trademark Office.
1 of 1
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M enu items for this site simply were all directed back to the M erck homepage. N o  
explanation was given about the product. This was a manipulative tactic as the website 
advertised in the magazine stated one thing, but the actual site w as something else.
Pfizer had the magazine website address o f  www.pfizer.com/ah. This site was for 
the animal health care products that were mentioned earlier under this company’s 
homepage description. M enu options for this site included: about Pfizer animal health, 
veterinarians, pet owners, and livestock. The information was fairly lengthy, however it 
was mostly for the veterinarian as it is technical in nature.
What was o f  interest with all o f  these ads was that the ones with website 
addresses were not necessarily the pharmaceutical companies that appear on Dun’s 
rankings. Glaxo W ellcom e had tw o ads for tw o different products but was ranked 
outside o f  the given parameters. Merck seemed to be active in promoting its website as 
its product features the address for its drug.
Chapter 5
DISCUSSION
The present research investigated six drug companies advertising 
pharmaceuticals on the Internet as well as three magazines advertising pharmaceuticals. 
The findings provided a broad background for understanding how  drugs are advertised 
on the Internet compared to other, more traditional mediums. From the investigation  
three main discussion points emerged. These points can be illustrated by using the 
theoretical framework o f  Lasswell and Wright (1960, 1976) and Doris Graber (1997). 
The three areas o f  discussion are: magazine portrayal, pharmaceutical company websites, 
individual drug advertisements and connections between the tw o mediums.
What the results showed was unexpected. From the literature review, one 
could extrapolate that the free flow  o f  information that the Internet allows for is o f  
concern regarding the lay population and pharmaceuticals (FD A  and the Internet, 1996). 
What was surprising about the findings was that overwhelmingly there was very little 
information about pharmaceutical products themselves. The vast majority o f  the 
information that w as presented w as information about the pharmaceutical companies, 
their role in the consumer culture, their role in the business culture, and generalized 
healthcare information. Little i f  any o f  the information involved in the websites dealt 
with pharmaceuticals.
Company history and community relation information took  up a lot o f  space 
with each company website. M uch o f  the information presented was geared toward the
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consumer in a public relations manner. Novartis had a management letter w ith its ‘ V h o
w e are” link that gave the mission statement for the company.
A s one o f  the w orld’s leading life sciences companies, Novartis is dedicated to  
creating value for its customers in the areas o f  Healthcare. Our commitment to  
Health, Safety and the Environment (HSE) is part o f  this dedication and is 
inseparable from our activities, our identity and our values. Excellence in Health, 
Safety and the Environment is not at odds with, but is rather intimately connected 
to our goal o f  providing the world with innovative products.
All o f  the company websites had similar items for customer relations or other such text, 
never were specific products mentioned.
The drug information that was presented on the websites was limited. Specific 
product names w ould be mentioned (i.e. Claritin) as a link would be built around the site 
o f  that particular product, but no more detailed information could be retrieved or was 
offered in the majority o f  cases. M ost product-specific links merely stated “ask your 
doctor” type referrals. Although little information was given, this type o f  link does 
confirm the literature in that companies are targeting the end-user to  direct the 
physician’s prescriptive inclinations (Consumer Reports, 1992).
Because the research showed that pharmaceuticals are big business (SIC, 
1996), the interest in monetary performance is logical. The obvious drive for the bottom  
line is fueled by the advertising expenditures earmarked by the companies (Conlan,
1996). All o f  the websites explored had a financial link which gave company stock  
information. Novartis, as w ell as a few  o f  the other companies had actual links to  other 
financial websites to  give the m ost current stock information. Again, specific 
pharmaceutical products were not mentioned.
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O f all the possible links, link options and their menu options, research and 
development seemed to be the best place to  find detailed information on specific 
pharmaceutical products. However, all o f  the w ebsites had public relation information 
which was akin to  company histories, but only a few  sites contained information where 
specific products were mentioned. Flonase from Glaxo W ellcom e was an example o f  
specific product being mentioned. The website had information about about the product 
and general allergy information. Schering Plough had Tinactin and Claritin information 
and specific sites built around those products. However, there were no other products 
mentioned in any o f  the websites which gave specific product information for other types 
o f  drugs. Athlete’s foot spray and allergy medicine were the featured products. N o  anti­
depressants or other schools o f  pharmaceuticals were mentioned. BM S research and 
development link was typical o f  the other companies.
(PRI) Pharmaceutical Research Institute is headquartered in Princeton, N ew  
Jersey, and is recognized leader in discovering and developing novel, cost- 
effective pharmaceutical therapies that improve people’s health and quality o f  
life. The PRI’s long tradition o f  preeminent scientific investigation has led to  
numerous advances in pharmaceutical treatment and prevention across the 
spectrum o f  medicine.
Magazine advertising
It is interesting that, in researching this area, much o f  the mainstream press has 
reported the issue o f  health and health care. For instance, three o f  the eight magazine 
issues during this research had cover stories on som e form o f  health. The M ay 26th 
edition o f  Newsweek had Asthma as its main cover story. Time had "How w e get
* th thaddicted" as its cover story for the M ay 5 edition, and "Natural Healing" as its M ay 12 
cover story. Far from drawing any conclusions, it is at least worth noting that these 
issues all had some form o f  pharmaceutical advertisements between their covers. The 
Newsweek May 12th edition had a cover story on China, and absolutely no drug 
advertising. N o generalization can be drawn from this; however, these facts help solidify 
the public’s awareness and concern about health care in all fashions and forms.
The magazine ads tended to  be loaded with information. Som e o f  the ads were 
balanced with lay terminology and traditional advertising approach presenting 
feature/benefit, yet there is little doubt that much o f  the ads were directed toward those 
in the medical profession. The technicalities o f  many o f  the ads support this observation. 
M ost o f  the ads were consumer-oriented in that they had elaborate layout with color 
graphics and photographs. M uch o f  the text w as for the lay person with information 
about heartburn interlaced with technical jargon.
Taken as a whole, the magazine ads did not convey a surveillance function in 
providing “new s.” The information presented did not necessarily inform either. M ost o f  
the data presented in the magazine ads gave technical information and attempted to find 
identification with the individual looking at the ad. For this reason, all o f  the magazine 
ads were considered correlative in nature. They editorialized on the information given. 
This was the selling point o f  the material presented. For example, headaches are not 
pleasant, but the ad for Glaxo's Imitrex showed a rebirth o f  sort for the user o f  the 
product. M ost assuredly, these can be labeled as socialization. They function to  
communicate values, and norms from the members o f  a society to a newcomer. I f  one
98
was a first time user o f  this product, one would not know  what to  expect. Such graphics 
helped to  illustrate what that individual can expect. It is not just aspirin, it is freedom. 
People w ho get older and need more medical assistance are prone to  be “initiated” into 
this culture by their peers, and m ost assuredly the companies. There are ways that are 
presented by the ads to gather more information, and adjust oneself to the jargon. 1-800 
numbers are given, as are guideposts to  see i f  one qualifies for the use o f  the product via 
a checklist o f  symptoms. I f  one has these symptoms, one qualifies for the treatment. 
Entertainment did not necessarily apply to  the magazine ads. They either informed in a 
minor w ay, helped the audience identify with the product, or point the way to more 
information. Graber's (1997) manipulation function did com e into play by the sheer 
nature o f  the medium. The ads attempted to  entice the consumer, create empathy, or 
create a need by playing upon the possibility o f  the consumer’s discomfort. Pain and 
“dis” ease are often shown in these ads. Perhaps this w as done to create empathy with  
the viewer. A  sense o f  identification with an ad is apt to  draw a viewer. This type o f  
logic can be traced back to transmitting a value or a culture.
Pharmaceutical websites
The company websites offered a host o f  information. Perhaps one o f  the 
biggest features o f  the websites was the financial news. These sites were all about 
information, from giving historical background on diseases to  providing press releases 
about new product development. They all qualified for the surveillance function. The 
correlative function was a bit more difficult to  apply to the company websites. 
Interpreting the environment w as not the primary function o f  the websites. I f  anything,
the magazines did a better job o f  correlation. They defined diseases or symptoms. The 
websites did not interpret the environment. M oreover, the magazine advertisements had 
more promotion o f  the product in their content than the company websites. Initial 
contact with a w eb page gave the browser many options for gathering information and 
different aspects o f  the company and health care as an entity. In examining the websites 
and Internet as a whole, it could be argued that they do in fact transmit information to  
"new" web users. There are several links on the company sites that allow for a tutorial 
showing how  to  navigate on the web. An example o f  this would be Lilly’s "search this 
web site" option.
Entertainment did play more o f  a role in the company websites than it did in the
magazine ads. A s the findings showed there were a mix o f  entertainment and
educational devices. However, Postman (1985) suggests that through technologically
advanced devices, information dissemination is not necessarily educational.
W e face the rapid dissolution o f  the assumptions o f  education organized around 
the slow-m oving printed word, and the equally rapid emergence o f  a new  
education based on the speed-of-light electronic image. There is a new  
conception o f  knowledge and how  it is acquired (Postman, 1985, p. 145).
There were "interactive" processes that a browser could engage in. V ideos 
could be ordered and cartoons appeared on some sites. There w as movement in some o f  
the graphic layouts o f  the home pages. For an example, M erck had moving graphics o f  
balloons as w ell as quizzes that people could play. FAQ ’s (frequently asked questions) 
were another option provided by many o f  the sites.
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Manipulation on the Web is difficult to assess. The very nature o f  the Internet 
allows for the browser to manipulate and navigate through the sites. In so doing, the site 
itself manipulates the browser by providing information and situations that the browser 
must "manipulate" in order to  access further information. B y its very nature this is a 
manipulative medium, but its interactive nature puts the media user in charge o f  key  
decisions. The companies control by limiting options on a particular site.
Magazine and website addresses
The magazine ads with website addresses fall under the surveillance function 
because the magazine ads provide the information (the website address) to  the audience. 
It is providing information and news. M ost o f  the ads asked the consumer to, "visit our 
w ebsite." The relationship betw een the tw o mediums is not correlative in nature. It is 
true that the magazine ads contain strong graphics, but there is no editorializing around 
the naming o f  the website address, other than the tame incitement o f  “com e visit.” The 
strongest function o f  the relationship between the tw o mediums w as that there was a 
socialization process. The magazine ads were communicating information, perhaps even  
values and norms from one generation to another. The literature review has shown that 
the Internet is an ever-growing medium (Liebman, 1995). The listing o f  a website in a 
traditional medium like a magazine ad is socialization. Entertainment was not evident in 
this relationship, however manipulation is. By the sheer function o f  a Web listing in a 
traditional medium such as a magazine, the audience is being manipulated to  "seek more 
information" by researching another medium. Such listings m ove the culture by 
suggesting use o f  the web has becom e a social norm.
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Even at the time o f  this research, there is continued growth in the Internet and 
health care. Patients w ho want to  know  the recommended treatments for their medical 
problems will have a place to  turn to in cyberspace under the new National Guideline 
Clearinghouse. This website will post the full range o f  treatment guidelines. The project 
is being developed with the American Medical Association and the American A ssociation  
o f  Health Plans, which represents health maintenance organizations and other managed- 
care plans.
This type o f  development is what fuels the F D A ’s concern over this new  
technology and the general public’s access to such information. The pharmaceutical 
companies have a history o f  being driven by the bottom  line, and as a result, the 
expansion into this new medium is cause for som e concern as a unique relationship is 
beginning to form with an information, tech n o-saw y public, and a profit driven industry.
However, what this research has shown is that there is no illicit behavior going  
on with pharmaceuticals on the web. I f  anything, there is a lack o f  information in this 
regard. The drug companies have a plethora o f  information but very little o f  it is in 
regards to actual pharmaceutical products. Yet, i f  the current players continue to be in 
the mix, there is great incentive, and very little cause for restraint in supplying the 
consumer with that information.
Limitations of the study
The major limitation o f  the study is the source that was examined in trying to  
find information about pharmacueticals. A s the FD A  is on guard about how  and what 
information is presented (Critser, 1996) and it appears that pharmaceuticals have a well
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documented history o f  using some questionable strategies for selling their products 
(Braithwaite, 1984), it would be surprising if  the pharmaceutical companies did promote 
their products on the Internet. Perhaps a better study would be to  examine other 
sources on the Internet that are promoting certain drug products. It could be that there 
is a group, individuals, companies, or other entity that is providing in-depth information 
about drugs that the consumer is looking for, and is posting this information on the 
Internet.
Another limitation o f  the study could be the timeframe o f  the research which 
w as not ample to look at trends and changes. A  one-month period is good  to get an 
initial reading, but as it was discovered, the w ebsites did not change in any dramatic way. 
Perhaps with a three-month w indow  o f  time or longer, one would be able to  see more 
changes in the text and layout o f  the websites. Over time, a long-term analysis could 
study evolution o f  the sites. Another limitation o f  the study is the choice o f  the magazine 
medium. Television might be a more comparable medium. H owever, one must take into 
consideration, that television advertising o f  pharmaceuticals is a relatively new  
development. In addition to this point, there is very little “text” in a television ad. 
M agazine advertising and the websites are compatible for the fact that they are both copy  
heavy. Another possible angle from which to  study this issue is by focusing on the 
specific product rather than company. To trace the product lifecycle might be more 
beneficial than to track it through the various mediums it may appear in.
The framework in which the study w as conducted might also be another 
weakness. Functional theory (Wright, 1976) has vast limitations. It is descriptive in
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nature rather than predictive. What is o f  concern to the FD A  is the possibility o f  
misinformation being disseminated on the Internet without any regulations. What would  
be most beneficial is to attempt to  predict the likelihood o f  this situation occurring.
What the research found was that there is virtually no drug information being presented 
by the pharmaceutical companies.
What is o f  concern is the potential power these pharmaceutical companies have 
in their drive for the bottom-line. (McQuail, 1987) suggests that the role o f  mass media 
is determined essentially by econom ic forces. In essence, the basic economic law o f  
supply and demand could dictate the future o f  the Internet and what information is 
provided regarding prescription pharmaceuticals. I f  there is a great enough demand by 
the public, these companies are prone to comply. A s it w as stated earlier in the research, 
there are no set regulations by a governmental body for this specific type o f  information 
for the Internet.
Future research
The most interesting aspect o f  this research w as to learn about the practices o f  
the pharmaceutical industry. Obviously, selling drugs is big business, and in the 
consumption driven econom y o f  America, the bottom-line is that much more deliberate. 
W e are consumers o f  information. It is a major part o f  our civilization. The purpose o f  
the information industry is to facilitate access to  the precise information needed at any 
specific time and place. Wolpert (1986) believes that know ledge is for three purposes: 
First, for fun or social interaction; second, for education, as essential building block facts
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that are required or may be advantageous to  acquire: and third, for making decisions or
assisting in action choices.
Information retrieval systems and the information industry are concerned with the 
creation, organization, and dissemination o f  knowledge from databases and the 
related aspects o f  processing, marketing, and communication. For an econom y 
to develop, it must have a good  information system. H ow ever, most economists 
have ignored the basic rules o f  information (Wolpert, 1986, p. 11).
Future research might be beneficial for both consumers and the government if
the information that is presented by these companies on their websites could be
scrutinized in detail. One would suspect that with the history o f  the companies, there
would apt to  be stretches in the “truth” presented on the websites. Another aspect for
study would be to  examine possible trends in the growth or decline o f  name brands on
the sites, and compare that to  the market share o f  that particular product.
The Internet has been impossible to ignore. Even people who are not computer 
owners and do not have access to get on-line, have been made aware o f  its 
growing popularity and effects on the population. It is sure to evolve into a 
medium o f  what is now  considered to  be the mass mediums; television, radio, and 
print. Credibility is an issue. The Internet makes few  such claims at the moment, 
and it is possible that the concept o f  credibility will also change as a result. 
Traditional mass media have addressed the issue within their organizations, hiring 
editors and fact checkers to determine what information is accurate. Source 
credibility will vary on the Internet,, with commercial media sites carrying 
relatively more credibility and unknown sources carrying less. A  much greater 
burden will be placed on the user to determine how  much faith to place in any 
given source. (Morris & Ogan, 1996, p. 44)
Such research as to how  the Internet can actually comply to the definition o f  a 
mass medium might help determine the validity o f  information. Yet, i f  the Internet is not
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considered a mass medium, how  can the information that is presented on the Internet be 
critiqued?
Nitcher (1989) sees the growing tendency to view  health as something one can 
obtain through the consumption o f  pharmaceuticals. A s self- medication is by far the 
m ost common medical action (Van der Geest, 1996) it is natural because it is convenient 
and economical. Self-medication is encouraged in reaction to overdependence on 
medical services. For consumers, it is a movement to assume greater responsibility over 
their ow n health. For the state, it is a w elcom e opportunity to econom ize on health care. 
It also benefits the pharmaceutical industry. Research could be done on the possible 
trends that may be occurring with populations in how they are receiving their medical 
information as with the example o f  w ebsite addresses in magazine ads, and whether or 
not people respond to  those addresses and go to  the websites.
To take it a step further, a viable topic o f  study could be to see if  people are 
reactive or pro-active to pharmaceutical advertising on the Internet. The possible 
number and age o f  a browser could help define whether or not the medium cross-over is 
effective, and with which demographic groups, if  any.
This early exploratory study o f  the Internet provided a starting point for fUture 
study o f  advertising on the Internet. While this study did not set out to explore the 
effects o f  this new type o f  advertising o f  pharmaceuticals, such studies in the future are 
inevitable. H ow  many people use the Internet as a source o f  medical information and a 
profile o f  who they are will be keys to  understanding the effect o f  this new
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communication technology. Continued systematic research by scholars is needed on the 
Internet in order to see possible abuses o f  the system.
Chapter 6
CONCLUSION
The specific topic o f  pharmaceuticals being advertised and promoted on the 
Internet is becoming a greater issue in the public’s mind. At the conclusion o f  this 
particular study there were several articles in national publications that addressed this 
matter. What may be the impetus for this growing concern is the fact that the FD A  has 
eased its regulations o f  television advertising for pharmaceuticals. The possible risks 
and/or side effects o f  taking a prescribed medication no longer are needed to be included 
in television advertising. Simply, all that is needed is the mention that som e risks may 
occur and an individual’s physician should be consulted.
With the broad and ever growing appeal o f  the Internet, access to certain kinds 
o f  information is cause for alarm in som e quarters. What this study has found may only 
be the initial prospectus for what is sure to becom e a hot topic in the national dialogue. 
Privacy issues abound in light o f  the information age, but with the open access to  
information concerning health factors, a peculiar twist emerges. D octors are the experts 
in consulting our health. Yet, i f  the lay person can diagnose and then prescribe his or her 
ow n treatment based on the amassing o f  information, the doctor may becom e only a 
middleman in the pharmaceutical delivery cycle. Moreover, the governmental role that 
has been the definitive gatekeeper for public health may find itself in jeopardy as more 
and more people are apt to turn to their ow n devices in the information age to medicate 
themselves.
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This study has drawn no specific conclusions on this topic. In fact, at the time 
o f  this study, the mounting fears and trepidation o f  certain groups were simply 
unfounded. The majority o f  the information that was displayed by the pharmaceutical 
companies on the Internet w as not product specific. The majority o f  the information 
could be found in other mediums and other sources. H owever, this does not mean that 
specific pharmaceutical information is not available. The study simply did not explore 
other options o f  this kind on the Internet.
M ost company websites explored in this study had lots o f  information 
regarding the company, health problems and concerns, and other varied information that 
did not involve specific pharmaceutical products. There w as no cause and effect, nor 
direct problem/solution scenarios. In other words, there w as no direct linking o f  a 
particular ailment to  a particular drug.
H ow ever, as there have been an easing o f  FD A  restrictions towards one 
medium, it may not be farfetched to concede to the possibility that the same may be true 
for the Internet in the future.
Appendix A
The Companies
Bristol-Myers Squibb Company
William McLaren Bristol and John Ripley Myers founded bristol-Myers Squibb 
Company in 1887. The merger o f  Bristol-Myers and Squibb Corporation in 1989 
marked the largest single stock transfer in the history o f  the health care industry at that 
time. The company dedicates over $20 million a year toward philanthropic endeavors. 
The company is the parent o f  high-tech operating units involved in pharmaceuticals, 
health care products and other areas o f  technology. Producer o f  cardiovascular, anti­
cancer, anti-infective and other such agents, its products include Capoten and Azactam, 
which are used as a medication for heart failure.
Pfizer Inc.
Pfizerlnc. is a research-based, global health care company. Their products are available 
in more than 150 countries. This company is the parent for many operating units 
involved in the manufacture o f  hospital products, pharmaceuticals, and chemicals. Over- 
the-counter drugs include Ben Gay, a topical muscular pain reliever, and Rid, a lice 
treatment. They are also the producers o f  anti-infective agents, psychotropic and
cardiology drugs. Products include Unasyn and Cefobid antibiotics, Zoloft 
antidepressants, and Cardura, a cardiology drug. Pfizer was formed in 1849.
Merck
Merck w as established in the United States in 1891, began its research program in the 
1930's and rapidly became known for its achievements in cortisone, and penicillin.
M erck estimates itself as conducting 5 percent o f  the world’s pharmaceutical research. 
Merck is the parent o f  high-tech units involved in the research, development and 
manufacturing o f  pharmaceuticals and chemicals.
Ciba-Geigy
This company is a non-U.S. company founded in Switzerland in 1940. Ciba-Geigy is a 
producer o f  drugs for arthritis, cardiac treatment, hormone balance, smoking cessation, 
attention deficit disorders, and obsessive-com pulsive behavior treatment applications. 
Other products include laxatives and analgesics. Products are sold to the medical and 
pharmaceutical industries. Habitrol, the nicotine patch, and Ritalin for attention deficit 
disorder are among its product line.
Eli Lilly
Founded in 1876, this company is a manufacturer o f  injectable and oral antibiotics, drugs 
and agents. Parent/holding company with units involved in the medical pharmaceutical 
and biotechnology industries. The bulk o f  revenue is derived form activity in the 
pharmaceutical industry. It has 26 ,000  em ployees with a 4% growth in the prior year. 
Am ong its product line is Prozac, an antidepressant drug, and Humulin, a drug for insulin 
treatment.
Schering-Plough
Formed in 1936, Schering-Plough is the parent o f  operating units involved in 
prescription and over-the-counter pharmaceuticals, vision care and animal health 
products, sun care and foot care products and research and development o f  allergic and 
inflammatory disorders and cardiovascular diseases. It has 21 ,000  employees with a 1-% 
employment reduction in the prior year. Drixoral, a sinus medication and Dr. Scholl’s 
are among its product line.
A p p en d ix  B  
C iba-G eigy/N ovartis
In Basel, Switzerland in late Decem ber 1996, the United States Federal Trade 
Commission (FTC) granted provisional approval to  an agreement with Ciba-Geigy and 
Sandoz, clearing the way for the creation o f  Novartis. With core businesses in health 
care, Agribusiness and Nutrition, Novartis had, in 1995, an R&D investment o f  3.5 
billion Swiss francs on pro-forma sales o f  36 billion Swiss francs. Novartis w as formally 
founded in early 1997 when the company w as registered in Switzerland, and its shares 
began trading soon thereafter on the Swiss stock exchange. The merger w as conducted  
through an exchange o f  shares. This merger became active in the United States on  
March 7, 1997.
Because o f  the timing o f  this merger and the study being conducted by the 
researcher, som e discrepancies do occur. At the time o f  the study, all three entities went 
by their individual namesake, while referring to the Novartis merger, but remained their 
own entity. While som e o f  the figures will be off, and some are simply non-existent, the 
validity o f  the study does not appear to be infringed upon. For the sake o f  argument, the 
researcher will use Ciba and N ovartis interchangeably, and keep the figures o f  the D un’s 
report, which are indicative o f  Ciba’s performance. Since Novartis is a new holding, 
there is no ranking for it in D un’s or otherwise.
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